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Investigating the Relationship Between Unavoidable, Hospital Acquired Pressure Injury
and Mortality: Is Unavoidable, Hospital Acquired Pressure Injury A Signal Of Increased
One-Year Mortality Risk?
Eileen Jimenez, Ph.Dc, RN
University of Nebraska, 2020
Supervisor: Janet Cuddigan, Ph.D., RN, FAAN
The purpose of this dissertation was to explore the strength of the relationship between
unavoidable Hospital Acquired Pressure Injury (HAPI) and increased risk of one-year mortality
for patients age 55 and older who were admitted to a hospital from 2015 to 2018. A quantitative,
retrospective case-control study was designed to compare demographics, comorbid conditions,
pressure injury risk, and living situation of those patients that developed unavoidable HAPI and
hospitalized adults with similar physiological burdens that remained injury-free. The one-year
mortality for the HAPI group was 27 of 48 (56%), and 26 of 47 patients (55%) for the Control
group. The HAPI subjects were more likely admitted to the ICU (p = .005), had a longer length of
ICU stay (p = .047), more orders for vasopressors (p < .001), greater use of vasopressors –
norepinephrine (p = .017); epinephrine (p = .004), phenylephrine (p = .001), and a greater total
number of vasopressors administered (p = .002). The discharge Braden Scale for Predicting
Pressure Sore Risk total score (p = .002) and subscale scores for Sensory (p = .002), Activity (p =
.022), Mobility (p = .019), and Friction/Shear (p < .001) were lower for the HAPI group.
Discharge Braden Scale total score (p = .001) and subscale scores for Activity (p < .001),
Mobility (p = .004), and Friction/Shear (p = .014) were lower for the HAPI subjects that died than
those that survived beyond one year. The Area Under Receiver Operating Characteristics curve
(AUROC) scores for the Charlson Comorbidity Index (CCI) were .655 (p = .006) for all patients,
.753 (p < .001) for the Control group and .544 (p = .519) for the HAPI group. Further research is

necessary to understand the effect of pressure injury on CCI scoring and determine the
importance of discharge Braden Scale scores to identify those at increased risk of mortality.
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CHAPTER 1
INTRODUCTION
It is often challenging to identify when patients, due to irreversible decline related to one
or more diseases and/or organ dysfunction, are nearing their end-of-life. Based on clinical
observation and data from a retrospective chart review, it was proposed that, in certain situations,
the development of an unavoidable pressure injury could be a signal of increased risk of mortality
within one year (Jimenez et al., 2017). A single-center, retrospective case-control study was
conducted to determine if there were any significant differences in risk for one-year mortality
between a group of 48 hospitalized patients who developed an unavoidable Hospital Acquired
Pressure Injury (HAPI) and a group of 47 similarly ill patients that remained HAPI-free.
Background
Approximately 33% of all older adults die within one-year post hospitalization, while 6070% of patients with HAPI will die in the same time frame (Brown, 2003; Gorina et al., 2015;
Manzano et al., 2014; Walter et al., 2001). Lyder et al. (2012) performed a secondary analysis of
the national Medicare Patient Safety Monitoring System database and found patients that
developed a HAPI were more likely to die than those that were pressure injury-free; the study
reported a mortality rate of 15.3% for patients with HAPI within 30 days after hospital discharge
versus a mortality rate of 4.4% for those who did not develop a pressure injury while hospitalized.
Song et al. (2019) completed a meta-analysis of studies reporting mortality differences between
patients with pressure injuries and those without and found those with pressure injuries had a two
times higher risk of mortality during a 3-year follow-up period.
What is unknown is whether persons who develop unavoidable HAPI have the same risk
for one-year mortality at the time of injury as hospitalized persons with similar primary problems,
co-morbidities, and hospital care, who did not develop a pressure injury. Understanding any
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differences in the two groups' mortality risks can guide future research regarding interventions
and care for those who develop pressure injuries as chronic conditions worsen. Understanding
similarities and differences can also guide decisions on analyzing and reporting HAPI rates.
Additionally, earlier referral to hospice care would be possible if a visible cue, such as
developing an unavoidable pressure injury, was known to signal the transition towards end-of-life
for those with chronic disease conditions. Early recognition of a change in health status would
provide an opportunity for the conversations between patients, families, and health care providers
that result in altering the focus of care from curative to hospice care when needed. End-of-life
(EOL) is defined as the period (hours, days, week, months) in a person's life when death cannot
be prevented (Segen's Medical Dictionary, 2011). Hospice care is provided for the terminally ill
who have a life expectancy of 6 months or less if the illness runs its normal course (CMS, 2019).
"When" to offer the type of care known to improve the EOL experiences for patients and their
families is often difficult to determine based on current gaps in knowledge.
Significance
It can be estimated that more than $180 billion, or 25% of 2018 Medicare spending, was
for services to beneficiaries in their last year of life (Cubanski et al., 2019; Riley & Lubitz, 2010).
Early recognition of EOL transition provides the opportunity to reduce overall health care costs
and improve the quality of life for the dying patient and their family. As Duncan et al. (2019)
reported, an analysis of Medicare expenditures found a three-fold difference in the expense for inhospital versus hospice care in the last six months of life, $39,230 versus $11,714. The use of
expensive treatments and extended hospital stays could end earlier and more compassionately if
patients and families, given complete information, elect to change the focus of care from curative
to hospice care. The National Hospice and Palliative Care Organization (NHPCO) reported that
of the Medicare patients who died in 2016, 48% were enrolled in hospice at the end-of-life; of
these, 54.2% were enrolled in hospice for 30 days or less and 27.9% for seven days or less

3
(NHPCO, 2018). Earlier referral allows for reduced costs and increased patient and family
support provided by a hospice program. The Institute of Medicine (2014) report recommended
improvement in communication and advanced care planning. Patients with congestive heart
failure and chronic obstructive pulmonary disease have survival rates and end-of-life experiences,
including frequent hospital admission and caregiver burden, comparable to those with cancer but
are less likely to be enrolled in hospice due to the difficulty in survival prediction as compared to
those with cancer (Lastrucci et al., 2018). While it is known that patients who develop pressure
injuries have a higher one-year mortality rate, there is a gap in understanding whether these
patients are at higher risk of mortality than those with similar illness burdens that do not develop
pressure injuries. The knowledge gained by this study adds to our understanding of the end-of-life
experience and the possibility that the development of an unavoidable HAPI may serve as a
signal of higher risk of one-year mortality, which can trigger communication between health care
providers, patients, and families regarding appropriate treatments and plans of care.
Prognostic uncertainty was cited by Fine (2018) as a barrier for early referral to hospice
care. Sensitivity and specificity analysis of prognostic hospice guidelines identify many patients
dying within six months who do not meet the guidelines. Many meet the criteria and live beyond
the expected six-months specified by Medicare. The Medicare hospice eligibility guidelines for
diagnosed diseases include the presence of Stage 3 and 4 pressure injuries for those with
dementia or amyotrophic lateral sclerosis (Vitas Healthcare, 2019). Pressure injuries also occur in
patients with other hospice eligible diseases, including cancer, renal failure, heart disease,
HIV/AIDS, and liver disease. Flauttau and Blank (2012) found a significant increase in one-year
mortality risk for patients with these conditions who developed a pressure injury.
While several prognostic studies with mortality as the outcome included the presence of a
pressure injury, no instruments were found that used pressure injury as a signal of the transition
towards end-of-life (Avelino-Silva et al., 2014; Bernabeu-Wittel et al., 2014; Gonzales et al.,
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2017). A retrospective study of Intensive Care Unit (ICU) patients found pressure injuries present
on admission may serve as a marker of increased risk of mortality (McGee et al., 2019). Further
understanding of the role of unavoidable pressure injuries in the months before end-of-life is
necessary to determine if they are related to impending mortality.
Conceptual Definitions of Key Concepts
Pressure Injury
The terminology describing pressure injuries has evolved. The term bedsore was
introduced by Florence Nightingale (1860/1969); bedsore did not reflect injuries that could occur
outside of the bed, and, by the 1990s, the term pressure ulcer became more common (EPIAP et
al., 2019). Currently, the term pressure injury has become more widely adopted as not all pressure
injuries have an ulcer with an opening in the skin surface.
The European Pressure Ulcer Advisory Panel (EPUAP), National Pressure Injury
Advisory Panel (NPIAP), and Pan Pacific Pressure Injury Alliance (PPPIA) (EPUAP et al., 2019)
agreed on an international definition of pressure injury as "localized damage to the skin and/or
underlying tissue, as a result of pressure or pressure in combination with shear. Pressure injuries
usually occur over a bony prominence but may also be related to a medical device or other
objects (p. 16)."
Two factors contribute to the development of pressure injury, the individual's
susceptibility and tolerance, and the magnitude and duration of a mechanical load. Individual
susceptibility and tolerance are related to internal anatomy; this includes tissue morphology, bony
structures, tissue repair capacity, mechanical properties of tissues, transport, and the tissues'
thermal properties. Mechanic loads include pressure, shear, and friction, although friction alone
will not cause a pressure injury (EPUAP et al., 2019).
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The international definition of pressure injury is modeled after the National Pressure
Injury Advisory Panel (NPIAP) definition as revised in 2016:
A pressure injury is localized damage to the skin and underlying soft tissue usually over a
bony prominence or related to a medical or other device. The injury can present as intact skin
or an open ulcer and may be painful. The injury occurs as a result of intense and/or prolonged
pressure or pressure in combination with shear. The tolerance of soft tissue for pressure and
shear may also be affected by microclimate, nutrition, perfusion, comorbidities, and soft
tissue condition. (Edsberg et al., 2016, p. 586)
The NPIAP also developed the most used system for classifying pressure injuries
(Edsberg et al., 2016). Pressure injuries are classified (or staged) according to the depth of tissue
involved. The categories of classification are listed below. See Appendix A for NPIAP definitions
for each category (Edsberg et al., 2016; NPIAP, n.d.).
•

Stage 1 – non-blanchable erythema of intact skin

•

Stage 2 - partial-thickness skin loss with exposed dermis

•

Stage 3 - full-thickness skin loss

•

Stage 4 - full-thickness skin and tissue loss

•

Unstageable - Obscured full-thickness skin and tissue loss

•

Deep Tissue Pressure Injury – persistent non-blanchable deep red, maroon or
purple discoloration.

Mucosal pressure injuries are not staged due to the unique nature of the tissue
involved. Medical device-related pressure injuries should be staged using the above
classification system, and the causative medical device should be noted.
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Avoidable and Unavoidable Pressure Injuries
Despite the implementation of pressure injury prevention interventions that are now
considered the standard of care for hospitalized patients, an average of 1.8 to 2.5% of hospitalized
patients continue to develop pressure injuries (Bauer et al., 2016; Morse, 2019). Pressure injuries
that occur despite implementing appropriate preventive interventions are considered unavoidable
(Black et al., 2011; Edsberg et al., 2014). Definitions for avoidable and unavoidable pressure
injures have been developed for two populations of patients, those in Long Term Care facilities
and those in other clinical practice settings. In 2004, the Centers for Medicare and Medicaid
Services (CMS) developed guidelines for Long Term Care facilities surveyors, which allows for
determinations that some pressure injuries are unavoidable. Per the guideline:
Unavoidable means that the resident developed a pressure ulcer/injury even though the
facility had evaluated the resident's clinical condition and risk factors; defined and
implemented interventions that are consistent with resident needs, goals, and professional
standards of practice; monitored and evaluated the impact of the interventions; and
revised the approaches as appropriate. (CMS, 2017 p. 278)
In 2011, the NPIAP adapted this definition and applied it to all clinical practice settings:
An unavoidable pressure ulcer can develop even though the provider evaluated the
individual's clinical condition and pressure ulcer risk factors; defined and implemented
interventions consistent with individual needs, goals, and recognized standards of
practice; monitored and evaluated the impact of the interventions; and revised the
approaches as appropriate." (Black et al., 2011 p.30)
Documentation of nursing and medical care is required to support the determination of
unavoidable. If appropriate interventions and care did not occur, then the injury is considered
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avoidable and attributed to the deficits in the patient's care and, therefore, are not an appropriate
indicator of a transition towards end-of-life.
High-risk status alone is not sufficient justification for an unavoidable pressure injury
determination. Unavoidable pressure injuries often occur when the magnitude and severity of risk
overwhelm reasonable efforts at prevention; some preventive strategies may be contraindicated,
and/or some risk factors are not modifiable (Edsberg et al., 2016). However, the determination
cannot be made a priori based on risk alone and requires an analysis of preventive measures'
appropriateness and adequacy.
Pittman et al. (2016) used the NPIAP definition as a framework to develop the Pressure
Ulcer Prevention Inventory (PUPI) instrument to identify avoidable and unavoidable HAPIs. The
PUPI instrument was used to categorize the HAPIs of 167 intensive care and step-down unit
patients in one Midwest U.S. hospital and found 67 (41%) of the patients had unavoidable
injuries (Pittman et al., 2019).
Theoretical Foundations
Coleman et al. (2014) developed a conceptual model to explain PI development risk
factors (see Figure 1). Using Coleman's approach, a revised conceptual model was created to
guide the study by including those factors known to increase one-year mortality (See Figure 2).
The Pressure Ulcer Conceptual Framework was created by Coleman et al. (2014)
utilizing systematic review and a consensus approach to identify the causal factors most
predictive of pressure injury. The conceptual framework also addressed pressure injury
development from a biomechanical, epidemiologic, and physiologic perspective. The conceptual
model emphasized the development of a pressure injury due to the imbalance of the external
biomechanical forces and individual physiologic ability to protect or recover. The conceptual
framework has two sub-concepts, Mechanical Boundary Conditions and Individual Susceptibility
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and Tolerance. Direct and indirect causal factors contributing to pressure injury development are
assigned to either of the sub-concepts. Mechanical Boundary Conditions are the extrinsic factors
that either increase direct pressure, duration of pressure, or contribute to skin and tissue
breakdown. The patient's inability to sense pressure and reposition to relieve pressure are known
pressure injury risk factors and are included in this sub-concept. Individual Susceptibility and
Tolerance are characterized by the individual's cellular responses to pressure and physiologic
conditions, which contribute to tissue breakdown, such as aging's physiological effects. At the
cellular level, adequate oxygen and nutrition affect the body's ability to respond appropriately to
pressure and prevent or repair tissue destruction and are included as components of this subconcept. The Coleman model has been utilized to explain intrinsic risks caused by chronic
diseases in the elderly and their relationship to pressure injury development (Jaul, Barron, et al.,
2018).
The sub-concept of Individual Susceptibility and Tolerance was of interest in this study.
It represents the patient's intrinsic risk factors. While some of these factors are modifiable (e.g.,
nutritional status, moisture, perfusion), others are non-modifiable (e.g., organ dysfunction or
disease) and more likely to be associated with unavoidable pressure injury and predictive of
mortality.
The modified model acknowledges that pressure injury does occur despite appropriate
nursing care. The biologic burden of comorbid conditions, or illness burden, results in an
irreversible decline that can precipitate pressure injury development (right side of Figure 2). The
burden overwhelms the body's ability to tolerate even normal pressure, and preventive
interventions are employed (left side of Figure 2). The imbalance between burden and
interventions results in the development of an unavoidable pressure injury.
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Figure 1
Pressure Ulcer Conceptual Framework

Note. The framework depicts the relationship between the sub-concepts of individual
susceptibility and tolerance and mechanical boundary conditions. Direct and indirect causal
risk factors are placed under the sub-concept they most affect; the interrupted line
acknowledges that some risk factors can affect both sides of the framework. From
"Discussion Paper. A New Pressure Ulcer Conceptual Framework" by S. Coleman, J. Nixon,
J. Keen, L. Wilson, E. McGinnis, C. Dealy, N. Stubbs, A. Farrin, D. Dowding, J. Schols, J.
Cuddigan, D. Berlowitz, E. Jude, P. Vowden, L. Schoonhoven, D. L. Bader, A. Gefen, C.
Oomens, & E.A. Nelson, 2014, Journal of Advanced Nursing, 70(10), p. 2232
(https://onlinelibrary.wiley.com/doi/epdf/10.1111/jan.12405). CC BY-NC
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Figure 2.
Modified Pressure Ulcer Conceptual Framework for Unavoidable HAPI

Note: The modified framework depicts the balance between standardized pressure injury prevention
interventions and the sub-concept conditions. The springs represent the interventions' effectiveness and
recognize that, at times, the impact of the sub-concept conditions exceed the interventions. Adapted
from "Discussion Paper. A New Pressure Ulcer Conceptual Framework" by S. Coleman, J. Nixon, J.
Keen, L. Wilson, E. McGinnis, C. Dealy, N. Stubbs, A. Farrin, D. Dowding, J. Schols, J. Cuddigan, D.
Berlowitz, E. Jude, P. Vowden, L. Schoonhoven, D. L. Bader, A. Gefen, C. Oomens, & E.A. Nelson,
2014, Journal of Advanced Nursing, 70(10), p. 2232 (https://onlinelibrary.wiley.com/
doi/epdf/10.1111/jan.12405). CC BY-NC. This adaptation was developed by Jimenez, E. & Cuddigan,
J. (2019).
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Purpose and Specific Aims
The purpose of this retrospective, case-control study was to explore the strength of the
relationship between unavoidable HAPI and increased risk of one-year mortality for patients age
55 and older who were admitted to a midwestern hospital from 2015 to 2018.
The specific aims of the study (comparing cases who developed an unavoidable HAPI
and matched controls that remained free of pressure injuries despite similar admitting diagnoses)
were to:
1. Determine the rate of occurrence of unavoidable pressure injuries in the HAPI
population using the PUPI tool.
2. Identify differences in comorbid conditions, pressure injury risk, demographics, and
living situations between those with unavoidable HAPI and the Control group.
3. Determine if patients who develop an unavoidable HAPI are more likely to die within
one year than the matched controls, who remained pressure injury-free during
hospitalization.
4. Identify risk factor differences in those with unavoidable HAPI that survive for one
year versus those with unavoidable HAPI that do not survive for one year.
It was hypothesized that the development of any unavoidable HAPI, of any stage, signals
a higher risk of one-year mortality due to intrinsic factors that may be irreversible.
Summary
A quantitative, retrospective case-control study was designed to compare demographics,
comorbid conditions, pressure injury risk, and living situation of those patients that developed
unavoidable HAPI and hospitalized adults with similar physiological burdens that remained
injury-free. The matching of patient pools based upon similarity in the primary reason for
hospitalization and age was unique in the study of pressure injuries and offered the opportunity to
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gain insight into the possible relationship between pressure injury and increased risk for one-year
mortality.
This chapter provides an introduction to this dissertation study. A review of the literature
on the primary concepts relevant to this study are discussed in Chapter 2. Chapter 3 describes the
study methods and instruments. Chapter 4 reports results associated with each specific aim.
Lastly, Chapter 5 provides a summary and synthesis of the results in relation to current
knowledge and implications for future research, education, and practice.
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CHAPTER 2
INTEGRATIVE REVIEW OF LITERATURE
The dissertation study planned to compare two groups, similar in illness burden and age,
to determine if the development of an unavoidable hospital-acquired pressure injury (HAPI)
signaled an increased risk of one-year mortality while accounting for age and illness burden. It
was necessary to identify the characteristics known to have statistical significance to risk for
mortality when comparing the one-year mortality rates of two groups of elderly patients, one with
unavoidable HAPI and the other without pressure injury. It is well documented that there is an
increased risk of one-year mortality for hospitalized patients who develop pressure injuries. Yet,
it is unclear whether this relationship is due to pressure injury or other comorbidities that
commonly occur in pressure injury patients (Song et al., 2019). Although numerous predictors of
mortality (including pressure injuries) have been explored, there is a paucity of information
describing the congregated characteristics of the individuals who develop pressure injuries and
perish within one year of hospitalization. The knowledge of these characteristics can help identify
patients at increased risk of pressure injuries near the end of life and, for those that develop
pressure injury, clarify whether that injury may be a visible signal of increased risk of one-year
mortality. Sibbald et al. (2010) recommended that research be conducted focusing on predictive
tools for the timing and measurement of skin changes at the end of life.
The integrative review process provided an opportunity to use the information gained in
multiple studies to identify and clarify the potential relationships among pressure injury, subject
characteristics, other organ dysfunctions, and conditions/situations which portend the risk of
mortality within one year. The information gained from the review process guided the selection
of variables for this dissertation study.
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Background
Several studies have reported an increased risk of one-year mortality for subjects who
develop pressure injuries; approximately 33% of all older adults die within one-year posthospitalization, while 60-70% of subjects with pressure injuries will die in the same time frame
(Brown, 2003; Gorina et al., 2015; Manzano et al., 2014; Walter et al., 2001). Song et al. (2019)
performed a systematic review and meta-analysis using eight studies; they found patients with
pressure injury to have a significantly increased risk of death (HR: 1.958; 95% CI: 1.79-2.14).
Pressure injuries continue to occur despite the implementation of timely and appropriate
preventive interventions. When pressure injuries develop under these conditions, they are
considered unavoidable (Pittman et al., 2019). Avoidable pressure injuries can be attributed to
deficits in preventive care. Unavoidable pressure injuries, particularly those occurring near the
end of life, have motivated some wound care experts to consider the possibility that some
unavoidable pressure injuries may be related to the continuum of progressive skin failure as an
individual nears the end of life (Langemo et al., 2010; Sibbald et al., 2010). Unfortunately, none
of the published studies investigating pressure injury development and mortality differentiate
avoidable and unavoidable pressure injuries or report on the emerging yet poorly defined skin
failure concept. We must assume that a mix of avoidable and unavoidable pressure injuries was
included in the studies examined for this integrative review.
Methods
An integrative review offers a systematic method to summarize empirical literature to
understand a healthcare phenomenon better. Whittemore and Knafl (2005) developed the
integrative review framework used to conduct this review. The integrative review process
consists of five stages: problem identification, literature search, data evaluation, data analysis, and
results presentation.
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A rigorous literature search, utilizing the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) framework, was conducted with a librarian's assistance
(PRISMA, 2015). Search terms for pressure injury included pressure ulcer(s), pressure injury(ies),
bed sore(s), bedsore(s), pressure sore(s), decubitus ulcer(s), decubital ulcer(s), terminal ulcer(s),
and skin failure; search terms for mortality included death, mortality, end-of-life, end of life,
terminal care, hospice care, and palliative care. The search occurred between June and September
2018.
The inclusion criteria for the review were journal articles on adult human subjects, full
text, written in English, published after 1967, and those that reported the results of multivariable
statistical analysis of pressure injury, comorbidities, and mortality. CINAHL, PubMed, and
Embase databases were queried for articles; also, hand searches for articles identified from cited
references and not found during the initial searches were completed (Figure 3). Articles were
excluded if they reported on subjects with spinal cord or neurologic dysfunction, included
children, had fewer than ten subjects, or included pressure injuries as the cause of death. The
exclusion criteria of neurologic dysfunction and spinal cord injury were intended to exclude those
subjects known to have a greater risk for unavoidable pressure injuries independent of end-of-life
concerns.
As a result of the literature review, mortality index studies reporting pressure injuries as a
predicting factor were discovered. A post hoc search focused on mortality indexes was
determined to be appropriate and was conducted to locate additional studies that considered
pressure injuries during mortality prediction instrument/index development. The terms used in the
post hoc search of PubMed, CINAHL, and Embase databases were "prognostic index, mortality
and development."
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Study/Data Evaluation
A quantitative article review checklist was developed to assess the articles that met the
search criteria. (Appendix B) The checklist assisted in identifying missing information considered
necessary with systematic evaluation of study results. Other appraisal tools influenced the
checklist (Guo et al., 2011; McMaster, 2018; Zhu et al., 2017). The assessed articles were
published in various decades and did not reflect more current published research expectations. An
article was considered acceptable if it included a problem statement, hypothesis, population of
interest, and statistical data applicable for the type of study conducted (Table 1). No study had all
the elements on the developed checklist; notably, statistical power information was not included
in any studies.
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Figure 3
PRISMA Diagram for Integrative Review

Records Identified Through Database
Search

Records Identified Through Other
Sources

(n = 1001)

(n = 11)

CINAHL = 230
PUBMED = 703
EMBASE = 68
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Records Screened

(see table)*

Title/Abstract

(n = 566)

(n = 621)

Full-text Articles

Full-text Articles

Excluded (See Table)**

(n = 55)

Articles Include for
Critical Appraisal
(n = 20)

(n = 35)
Reason For Article Exclusion

*Title/Abstract
Review

PU Not Specifically Identified

406

3

Mortality Statistics Not Included

120

11

Included SCI/Neuro

31

2

Included Children

1

0

No Comorbidities

0

2

Less than 10 Subjects

3

1

Unavailable from Library

0

1

Not a Research Study

2

1

Not Full Text

1

0

PU Cause of Death

1

0

Incidence/Prevalence Study

1

3

No Multivariate Statistics

0

11

566

35

Total Excluded

**Full Text
Review
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Table 1

Lit Review

Framework/Theory

Hypothesis Variables

Study Design

Sample

Measurement

Statistics

Findings

1

Avelino-Silva et al., 2014

+

-

+

+

+

+

+

+

+

2

Badia et al., 2013

+

-

-

+

+

+

NR

+

+

3

Bernabeu-Wittel, et al, 2014

+

-

-

+

+

+

+

+

+

4

Carey et al., 2008

+

-

-

+

+

+

+

+

+

5

Flatau & Blank, 2012

+

-

-

+

-

+

NR

+

+

6

Gambassi et al., 1999

+

-

-

+

+

+

NR

+

+

7

Gonzalez et al., 2017

+

-

-

+

+

+

+

+

+

8

Hung et al., 2002

+

+

-

+

+

+

NR

+

+

9

Ireland et al., 2015

+

-

-

+

+

+

NR

+

+

10

Iwata et al., 2006

+

-

-

+

+

+

NR

+

+

11

Jaul et al., 2016

+

+

-

+

-

+

NR

+

+

12

Jaul & Rosenzweig, 2017

+

-

-

+

+

-

NR

+

+

13

Jaul et al., 2017

+

-

-

+

+

+

NR

+

+

14

Khor et al., 2014

+

+

-

+

+

+

NR

+

+

15

Landi et al., 2007

+

-

-

+

+

+

NR

+

+

16

Lyder et al., 2012

+

-

-

+

+

+

NR

+

+

17

Maida et al., 2009

+

+

-

+

+

+

NR

+

+

18

Manzano et al., 2014

+

_

-

+

+

+

NR

+

+

19

Thomas et al., 1996

+

_

-

+

+

-

+

+

+

20

Zafrir et al., 2010

+

-

-

+

+

+

NR

+

+

Study Number

Problem Statement

Methodologic Assessment of Quantitative Studies with Pressure Injuries

Study

Note. Result of assessment of qualitative studies utilizing an appraisal form
+ Included the methodological item(s); - did not include methodological items(s); NR not relevant
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Data Analysis
The studies all reported the risk of mortality for those with pressure injuries. Nineteen of
the 20 studies found an increased risk for mortality within one year for those with a pressure
injury. When reviewing the articles, three categories became apparent.
1. Studies of pressure injury patients (and controls) which examined risk factors for
mortality.
2. Studies of specific disease entities that looked at the relationship between pressure
injury and mortality.
3. Studies that reported the development and validation of a prognostic index for
mortality and included pressure injury as a possible risk factor.
Multivariate statistical analytical methods were used to determine one-year
survivability/mortality risk. Comorbidities were identified that, along with the pressure injury,
were found to be a significant risk factor (p ≤ .05), for increased one-year mortality (see Table 2).
Tables that reported the risk of mortality for those with pressure injures in the three types of
studies were created (Tables 3-5). The tables provide a synopsis of the study, setting, number of
subjects, and the findings. Table 3 provides information on the relationship between pressure
injuries and comorbidities; Table 4 reports the relationship between a specific disease or
condition and pressure injuries; Table 5 presents the odds ratios reported for pressure injuries in
multivariate analysis conducted during the development of mortality prediction instruments.
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Table 2
Variables Reported as Significant Risk Factors for One-Year Mortality in Studies that Also
Reported Pressure Injury as a Significant Risk Factor *
Participant
Characteristics

Situation

Disease/Organ Failures/
Conditions

Age 65+ 5,7,10,13, 20

Bed Bound 14

Cancer5,16,17

Hispanic 5

Braden Score < 12 14

Cardiac 7,16

Male 5,11

Co-Morbidity Damage Index 19

Cerebrovascular 7,15

Corticosteroid Use 16

Chronic Medical Condition 3

DRG Weight (Reimbursement for
care) 5

COPD 16

Home Care Subject 2,8
MD expects <5 yr. survival
Mechanical Ventilation

19

18

Dementia 2,11-13
Diabetes 5,16
Frailty 4,15
Hematocrit % 5

Resides in Nursing Home 14
Weight Loss in last 6 months

19

Hip Fracture 9
Infection 5,14
HIV/AIDs 5
Liver Disease 5
Low Albumin 14
Low Hemoglobin 17,12
Neutrophilia 14
Obese 16
Parkinson’s 12
Peptic Ulcer 5
Pressure Injury-Stage 4 14
Pressure Injury Present on
Admission 1
Renal 5
Urinary Incontinence 14

Note. The variables were found to be a significant univariate risk factor, p ≤ .05, for one-year
mortality in studies that also found pressure injury to be a significant risk factor.
*The Study Number found in Table 1 indicates the source(s) for the variable.
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Table 3
Risk Factors for Mortality in Populations with Pressure Injuries
Study (Year)
Flattau & Blank
(2012)

Setting
US.
HospitalAcquired

Sample Size

Comorbidity or Situation and Mortality

PI Count

Odds Ratio/Relative Risk/Hazard Ratio (95% CI)

6296

< 90 Day Survival
Age = 1.02*

All with PI

Male = 1.15* (1.06-1.24)
Hispanic = 1.13* (1.01-1.26)
Sepsis = 1.50* (1.37-1.63)
Diabetes = 1.31* (1.12-1.55)
CHF = 1.35* (1.25-1.47)
Chronic Renal Failure = 1.46* (1.35-1.59)
Liver Disease = 1.21* (1.07-1.36)
HIV/AIDS = 1.40* (1.09-1.79)
Myocardial Infarction = 1.35* (1.20-1.52)
Cerebral Vascular Disease = 1.17* (1.06-1.29)
Metastatic Cancer = 2.48* (2.06-2.99)
91-180 days Survival
Age = 1.01* (1.01-1.12)
Male = 1.37* (1.16-1.62)
Hispanic = 1.61* (1.30-2.00)
Diabetes = 1.63* (1.14-2.34)
Chronic Renal Failure = 1.34* (1.12-1.60)
CHF = 1.26* (1.07-1.50)
Metastatic Cancer = 1.53* (1.06-2.22)
Peptic Ulcer = 1.50* (1.01-2.23)
Any malignancy = 1.62* (1.23-2.12)

Jaul et al.

Israel

99

(2016)

Geriatric
Unit

All with PI

Jaul & Rosenzweig
(2017)

Israel

192

Geriatric
Unit

All with PI

96 days mean Survival
Dementia = 3.86* (1.82-8.198)
122 days mean Survival (82-192)
Chronic Disease = 1.14* (1.068-1.206)

Note: Study information - setting, samples size with number of subjects with pressure injury, and
variables found to be significant univariate risk factors, p ≤ .05, for one-year mortality.
*Hazard Ratio. ** Relative Risk. ***Odds Ratio
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Table 4
Risk of Mortality for Subjects with Specific Disease/Conditions and a Secondary Diagnosis of
Pressure Injury
Study (Year)

Setting

Sample Size

Disease/Condition

PI Count

Badia et al.

Spain

1001

(2013)

Home Care

PI=131

Pressure Injury and Mortality
Odds Ratio/Relative Risk/Hazard Ratio
(95% CI)

Chronic Illness

1-Year
PU Stage 1 or 2 = 3.00*** (1.94-4.65)
PU Stage 3 or 4 = 4.33*** (1.81-10.4)

Gambassi et
al.

US.

9264

(1999)

Nursing
Home

PI=951

Hung et al.

Taiwan

322

(2002)

Community
Dwellers

PI=66

Ireland et al.

Australia

2522

(2015)

Veteran
Hospitalized

PI=367

Iwata et al.

Japan

403

(2006)

Discharged
from Hospital

PI=79

Maida et al.

Canada

418

(2009)

Palliative
Care

PI=95

Israel

333

Hospitalized

PI=69

Zafrir et al.
(2010)

Cognitive
Impairment
Chronic Illness

≤ 23 Months
PU = 1.24** (1.31-1.36)
1-Year
PU = 3.296*** (1.043-3.750)

Hip Fracture

30-365 Days
PU = 1.3* (1.1-1.6)

Age 85+

1-Year
PU = 1.84* (1.14-2.97)

Cancer

23 days Median
PU = 1.85* (1.44-2.37)
PU & Female = 2.00* (1.38-2.89)

Age ≥ 90

< 23 Months
PU = 2.72*** (1.43-5.22)

Note. Study information – setting, samples size with number of subjects with pressure injury, and oneyear mortality risk for pressure injury in univariate analysis. *Hazard Ratio.** Relative Risk. ***Odds
Ratio
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Table 5
Pressure Injuries Included in Predictive Model for Mortality
Study
(Year)

Setting

Sample Size

AvelinoSilva et al.
(2014)

Brazil

746

Geriatric Unit

PI=50

BernabeauWittel, et
al. (2014)

Spain

1,778

≤ 6 Months

Geriatric/Internal
Medicine
Units/Clinics

PI=29

PI = 1.75* (1.06-288)

Carey et al.
(2008)

US.

Index
Development

PI Count

Frail Elderly
enrolled in-home
care program

2,232

Mortality Risk with Pressure Injury
Odds Ratio (95% CI)
In Hospital Death
PI = 2.29* (1.04-5.07)

≤ 6 Months
PI found not significant

PI=48
Index
Validation
1,667
PI=62

Gonzales
et al.
(2017)

Spain

903

Hospitalized

PU=62

≤ 6 Months
PI = 1.6* (1.0-2.5)

Note. Study information – setting, sample size with number of subjects with pressure injury, and oneyear mortality risk for pressure injury in multivariate analyses. *p

≤ .05
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Results
The search identified 1,001 articles: CINAHL (n = 230); PubMed (n = 703); and Embase
(n = 68). Post-hoc search and additional articles identified through reference searches found an
additional 11 articles. There were 391 articles found to be duplicates and were excluded; then, an
additional 566 articles were excluded utilizing title and abstract screening. A full-text assessment
of the remaining 55 articles resulted in 35 studies being excluded. The reasons for exclusion are
shown in Figure 3.
It was assumed that the relationship between pressure injuries and mortality would be
reported in wound care literature. An unexpected finding was the link between pressure injuries
and mortality reported in other healthcare literature. Seven studies were designed from a disease
or condition perspective (Badia et al., 2013; Gambassi et al., 1999; Hung et al., 2002; Ireland et
al., 2015; Iwata et al., 2006; Maida et al., 2009; Zafrir et al., 2010). Four studies focused on
developing general mortality prediction instruments (Avelino-Silva et al., 2014; Bernabeu-Wittel
et al., 2014; Carey et al., 2008; Gonzalez et al., 2017). The 20 studies were sorted into categories:
studies of subjects with pressure injuries, studies of subjects with a specific disease/condition, or
studies designed to develop prognostic mortality instruments. The sorting provided an
opportunity to compare similar statistical data. The inclusion of pressure injuries as a covariate of
interest in studies outside the wound specialty arena reflects the findings' significance as they
were consistent across settings and disease/conditions.
All the articles were published in peer-reviewed journals and spanned the years from
1996 to 2017. Expectations of methodological rigor could not be evenly applied due to the change
over time in published research; therefore, it was not expected that any study would meet all the
methodological criteria. All studies employed appropriate statistical analytical choices; however,
no study reported power analysis. One study utilized a theoretical framework (Avelino-Silva et
al., 2014). All the studies reported adequate information for the evaluation of appropriate study
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design and hypothesis, populations were suitable for inclusion, and conclusions were consistent
with the findings. No study meeting the review criteria was excluded.
Specific Aspects of the Literature
The 20 articles reported quantitative studies conducted in 10 different countries (U.S.,
Israel, Kuala Lumpur, Italy, Spain, Taiwan, Australia, Japan, Canada, and Brazil). Care settings
included hospitals, geriatric units, nursing homes, palliative care, and community dwellers
receiving various nursing services and support. Subject sample sizes varied from 99 to 51,842 and
included subjects age 55 or older. A variety of multivariate statistical approaches were used
across the studies to determine if pressure injuries were a factor for increased risk of mortality in
subjects.
The development of a pressure injury was considered a statistically significant risk factor
for one-year mortality in the final analysis in 19 of the 20 studies reviewed. The study subjects
were located in a variety of settings: six studies collected data on subjects admitted to skilled
geriatric units or nursing homes (Avelino-Silva et al., 2014; Bernabeu-Wittel et al., 2014;
Gambassi et al., 1999; Jaul et al., 2016; Jaul & Rosenzweig, 2017; Jaul et al. 2017). nine studies
followed subjects that had been hospitalized (Flauttau & Blank, 2012; Gonzalez et al., 2017;
Ireland et al., 2015; Iwata et al., 2006; Khor et al., 2017, Landi et al., 2007; Manzano et al., 2014;
Thomas et al., 1996; Zafir et al., 2010), and community/home subjects were the focus of five
studies (Badia et al., 2013; Carey et al., 2008; Gambassi et al., 1999; Hung et al., 2002; Landi et
al., 2007). The findings' consistency strongly suggests that the pressure injury development is
multifactorial and often related to end-of-life.
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Subjects with Pressure Injuries
The relationship between pressure injuries and risk for mortality was the focus of nine
studies (Table 3). The risk of mortality was analyzed with the characteristics of subjects with
pressure injuries or in those with pressure injuries and comorbidities. All the studies reported the
increased risk of mortality for subjects with pressure ulcers. Lyder et al. (2012) found that
pressure injuries were not independently associated with mortality but were correlated with
selected diseases and conditions associated with increased mortality. Three of the studies that
included dementia as a comorbidity of interest had the same lead author and were from the same
study site, and two with the same sample size, but different subjects. (Jaul et al.,2017; Jaul et al.,
2017; Jaul & Rosenzweig, 2017).
Specific Disease/Condition and Pressure Injury
Seven studies focused on subjects with specific diseases or conditions. They found
pressure injuries to be a significant factor associated with an increased risk of mortality, as shown
in Table 4.
Presence of a Pressure Injury in Mortality Prognostic Instruments
The development of instruments to predict mortality was the goal of four studies in which
pressure injuries were considered for inclusion. Three studies found pressure injuries to be a
statistically significant factor for mortality risk prediction (Avelino-Silva, 2014; Bernabeu-Wittel,
2014; Gonzalez et al., 2017). Carey et al. (2008) was the only study reporting the exclusion of
pressure injury in the final predictive model as the p-value was greater than .05. Table 5 indicates
the odds ratio for one-year mortality when a pressure injury was present.
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Discussion
The purpose of this integrative review was to identify studies that explored the characteristics
of subjects who developed a pressure injury and died within one year. The variety of disease
states, settings, and situations found during the review process demonstrates pressure injuries'
omnipresence. The consistency in the reported statistical significance of the pressure injuries to
risk of mortality supports the concept that the development of a pressure injury could signal endof-life. It also demonstrates that end-of-life prediction is complex and based on multiple factors;
the unique and specific role of pressure injury as a predictor of one-year mortality has not been
fully elucidated,
If some pressure injuries are signals of an end-of-life transition, it is essential to pursue a
standardized method to identify these injuries. Jaul and Rosenzweig (2017) discussed the clinical
and ethical implications of knowing the survival time for subjects in various settings. Also,
recognizing the intrinsic conditions which co-occur with pressure injury provides the clinician the
opportunity for improved clinical planning (Flattau & Blank, 2012; Jaul et al., 2016).
The review's limitations include the limited post hoc search for predictive mortality
instruments as relevant studies may not have been identified. The recognition of significant
relationships may have occurred, but it is impossible to determine due to the lack of reported
power analysis. Also, the stages of the pressure injuries were not included in all the studies; this
may be important as the tissue injury depth may have a relationship with mortality, as suggested
by Song et al. (2019).
Conclusions
The variety in settings, diseases, conditions, and situations found in the reviewed studies
indicates pressure injuries' pervasiveness. The studies' variations also show the diversity of
clinical practices and practitioners recognizing the relationship between pressure injury and
mortality.
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Characteristics identified in two or more studies as significant for increased risk of one-year
mortality for those with pressure injury included age 65 and older, home care subject, cancer,
dementia, diabetes, frailty, infection, low hemoglobin, and cardiac and cerebrovascular disease.
These identified factors can guide future research into unavoidable pressure injury as a visible
signal of impending mortality.
Early identification of the subject at increased risk for one-year mortality could provide
opportunities for the patient and family to establish preferences regarding end-of-life goals and
resolve uncertainties that can negatively impact quality of life (Lund et al., 2015).
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CHAPTER 3
METHODS
Research Design
A single-center, retrospective, case-control design was selected as an appropriate method
to study phenomena with a low incidence in the populations (Niven et al., 2012). The HAPI
incidence rates in acute care hospitals in the U.S. were reported to be 2.4% (Morse, 2019). There
is limited information on the rate of HAPI that is considered unavoidable. A study conducted by
Pittman et al. (2019) found 67 (41%) out of the 167 patients with HAPIs had unavoidable injuries
using the Pressure Ulcer Prevention Inventory (PUPI) tool.
Setting
Nebraska Medicine is a 700-bed acute care facility in Omaha, Nebraska, which serves as
the primary teaching site for students enrolled in the University of Nebraska Medical Center
(UNMC) health professions programs. As a Level 1 Trauma Center, National Cancer Institute
(NCI) recognized Cancer Center and multiorgan Transplant Center, Nebraska Medicine is a
regional, national, and international referral center that routinely cares for very complex highacuity patients. Nebraska Medicine participates in the National Database for Nursing Quality
Indicators (NDNQI) surveys, providing accurate identification of hospital-acquired pressure
injuries based on bedside skin assessments performed and validated by certified wound care
nurses.
The Electronic Health Records (EHR) Data Access Core facility at UNMC provides
access to Electronic Health Care data for clinical and translational research, including feasibility
studies, cross-sectional studies, health outcomes, retrospective data analysis, quality improvement
projects, transfer of datasets to a registry, case finding for subject recruitment, and public health
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research. This study proposal was submitted to and approved by the University of Nebraska
Medical Center Institutional Review Board (#310-20-EP).
Sample
The sample was comprised of cases identified as having HAPI in NDNQI surveys, which
were determined to be unavoidable using the PUPI tool. The Control group consisted of nonHAPI patients hospitalized during a similar time frame and matched for admitting diagnosis and
age range using the UNMC EHR Data Access Core services.
Inclusion Criteria
Patients aged 55 and older, hospitalized at Nebraska Medicine for at least five days in
2015 through 2018, were the study subjects. The years were chosen to allow for one-year posthospitalization death to occur before the study start. The minimum stay of five days allowed for
the necessary data collection to determine the injury's avoidability.
Exclusion Criteria
Patients were excluded if they had spinal cord injury, had pressure injuries on admission,
or were under hospice care at the time of admission. Exclusion criteria were created to address
confounders that might occur as patients with spinal cord injuries have known greater risk for
pressure injuries independent of end-of-life concerns. Hospice patients have already been
assessed for imminent mortality, and comfort care protocols have priority over pressure injury
prevention protocols. Pressure injuries present on admission may act as confounders during
electronic data collection. Additionally, pressure injuries that are deemed avoidable using the
PUPI tool may be related to care conditions instead of the patient's physiologic decline.
Sample Size
G-Power (Version 3) software was utilized to calculate the sample size. Options chosen
were Exact as the test family, Fisher's Exact as the statistical test, a priori power analysis, and two
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tails. Proportions of .3 and .6 were used to reflect the one-year mortality rates reported in the
literature. Gorina et al. (2015) completed an analysis of Medicare patients age 65 and older and
reported that 33.9% died within 30 days post-hospitalization, with an additional 17.8% dying 31365 days post-discharge. A 60% rate for mortality for those with hospital-acquired pressure
injuries was selected as reported rates varied from 60% to 75% (Manzano et al., 2014; Brown,
2003). An alpha of .05, a power of .80, and an allocation ratio of 1 were selected for this study.
The G-Power software program's output indicated a sample size of 48 for each of the two groups.
The study's goal was to identify 48 cases and 48 controls; however, as pressure injuries were
not routinely included in the patient's problem list, matching was difficult. During the final data
collection of the patient information, a subject assigned to the non-HAPI group was found to have
a HAPI and removed from the group; this resulted in the HAPI group having 48 cases and the
non-HAPI Control group having 47.
Data Collection
Case Selection
Data gathered by nursing staff and certified wound care nurses during quarterly NDNQI
prevalence surveys conducted between January 2015 and December 2018 were used to identify
HAPI patients. The Nurse Manager of the Hyperbaric Medicine and Wound Ostomy Continence
Services provided a list of patients verified as having HAPI in the NDNQI surveys conducted
during the inclusive dates. Use of NDNQI prevalence survey data guaranteed that a wound nurse
verified the pressure injury diagnosis and staging and that a rigorous standard methodology for
data collection was followed (Waugh & Bergquist-Beringer, 2016, 2020). The primary
investigator reviewed the electronic health records for each of the 223 patients identified as
having a HAPI. Charts were reviewed for inclusion and exclusion criteria. Figure 4 provides
information on the results of the review of the HAPI patients for study inclusion. The Pressure
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Ulcer Inventory (PUPI) tool was used to determine the pressure injury's avoidability and is
discussed later in this chapter.

Figure 4
HAPI Case Selection Process

Quarterly Prevalence Survey Results
2015-2018
223 Patients in HAPI Group

Reason for Exclusion

Number

Too Young (<55)

45

Less than 5-day Length of Stay

44

for Inclusion & Exclusion Criteria

Pressure Injury on Admission

39

79 Remaining in HAPI Group

History of Spinal Cord Injury

7

No Records found in EHR

6

Enrolled in Hospice on Admission

1

No Pressure Injury found in EHR

1

Repatriated out of U.S., no follow-up

1

After EHR Search

After Unavoidable Determination
Using PUPI Tool
61 Unavoidable HAPI
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Case Data Collection
The focus of information extraction was threefold, identifying data related to the
physiologic burden of illness, pressure injury information, and demographic data, which might
contribute to understanding the characteristics of those who develop pressure injuries. The aim to
compare two groups of similar age and illness burden necessitated reviewing the patient's history
and the primary reason for the hospitalization of interest. The comorbid conditions identified in
the Integrative Review were used to search for a mortality risk tool; the Charlson Comorbidity
Index (CCI) was chosen to represent both risk for one-year mortality upon admission and the
illness burden inherent in a patient's medical history. The standardization of illness burden using
the CCI scores allowed for comparisons between and within the two groups. The CCI data
included age at admission and 17 conditions known to be associated with mortality; this tool is
described in this chapter's Instrument section.
The information collected on pressure injury had the date of injury identification, location
of pressure injury, stage of pressure injury on date of discovery and discharge, and if the pressure
injury was reported in the patient's problem list of the EHR. If more than one pressure injury was
present, the wound with the deepest degree of tissue damage or the injury that was over a bony
prominence was chosen as the injury of interest. Braden Scale total scores and subscale scores
were collected for the day of admission, the day the pressure injury was first identified, three days
before pressure injury discovery, and on the day of discharge. The Braden Scale is discussed in
the instrument section of this chapter.
Demographic data included admission and discharge dates, age on admission, gender, the
living situation at the time of admission and discharge, date of admission, and death date.
Hospitalization data included the International Classification of Diseases (ICD) for the primary
reason for hospitalization, days in Intensive Care Unit (ICU), number of surgeries during
hospitalization, longest anesthesia time, number of days mean arterial pressure (MAP) was
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collected, highest and lowest MAPS outside of normal range, use and types of vasopressors, and
rapid response and code blue occurrences.
Control Selection and Data Collection
Except for pressure injury information, the same data were collected for those in the nonHAPI group. The selection of patients for the non-HAPI group proved to be more difficult than
anticipated. Multiple meetings with those who extract research data from the hospital records
initially indicated the ability to pull matching control by ICD 10 codes, gender, and the CCI age
range while excluding patients with HAPI. ICD 9 codes were converted to corresponding ICD 10
codes. Three problems occurred: the discovery that the information regarding pressure injuries
was not routinely entered into fields that could be used for extraction; the specificity of ICD 10
codes made it difficult to find exact matches, and the CCI age range limited matching. After the
initial data pull, the matching criteria were changed to disregard gender and allow for similar ICD
10 codes and age within 10 years of the matching HAPI patient, with a minimum age of 55. As
the goal of matching was not to have exact one-to-one matching but to create two pools of equal
illness burden, so the pressure injury's significance could be explored independent of
comorbidities. The modification in the matching criteria was deemed appropriate.
Four data extraction "pulls" were required to meet the minimum sample size (see Figure
5). Due to the complications with global extraction, each case had to be identified by an
individual search by one individual who was aware of the study data needs. The primary
investigator conducted all chart review to ensure consistent data collection.
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Figure 5
Non-HAPI Matched Control Selection Process
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Instruments
Charlson Comorbidity Index
The Charlson Comorbidity Index (CCI) was developed to classify the one-year mortality risk
for hospitalized patients (Charlson et al., 1987; Sundararajan et al., 2004; University of Manitoba,
2019). The index weighs 17 comorbidities and age: ages 55-60 are two points; 61 to 70 are three
points; and ages 71 and older are 4 points (see Appendix C). One point is assigned for a history of
acute myocardial infarction, congestive heart failure, peripheral vascular disease, cerebral
vascular accident, dementia, pulmonary disease, connective tissue disorder, peptic ulcer, liver
disease, and diabetes without complications. Two points are given for a history of diabetes with
complications, para and hemiplegia, renal disease, and non-metastatic cancer. A history of
metastatic cancer and severe liver disease are awarded 3 points, and HIV/AIDS is assigned 6
points. The higher the cumulative score, the higher the risk for one-year mortality; (Charlson et
al., 1987). CCI is one of the most extensively studied comorbidity indexes and is reliable and
valid in different cohorts and settings (Bannay et al., 2016). Individuals with scores greater than
five have been shown to have 85% one-year mortality. When using ICD-10 for comorbidities, the
area under the Receiver Operating Curve (ROC) characteristics was .855, with one-year mortality
as an outcome (Sundararajan et al., 2004). As the implementation of ICD-10 code usage varied by
institutions, both ICD-9 and 10 codes, extracted from the electronic health record (EHR), can
identify patient comorbidities and associated scores. A study utilizing EHR information reported
specificity of the CCI instrument was greater than 93 percent for all comorbidities (Youssef &
Alharthi, 2013).
Braden Scale
The Braden Scale for Predicting Pressure Sore Risk, developed in 1984, is commonly
used by hospital nurses to categorize risk for pressure injury development and guide interventions
(see Appendix D). The instrument has six subscales: sensory perception, moisture, activity,
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mobility, nutrition, and friction and shear. The subscales have weights ranging from 1 to 4, except
the friction-shear subscale with a maximum score of 3. The lower the total score, the higher the
risk for pressure injury development. A maximum score is 23; a score of 15-18 indicates the
patient is at risk; 13-14 is a moderate risk; 10-12 is high risk, and nine or lower places the patient
at very high risk of injury (Bergstrom et al., 1987). However, prevention should be guided by the
specific risks in the subscale scores, additional risk factors, and clinical judgment (EPUAP et al.,
2019). The instrument has been validated in different populations and settings; content validity is
reported as excellent with a value of .99 (Kring, 2007). Ho et al. (2016) reported a high interrater
reliability level of the total score (ICC = .807). A methodological review of sixteen studies on the
psychometric qualities of the tool found median sensitivity of .74 (.33 to 1) and median
specificity of .68 (.34 to .86) (EPUAP et al., 2019). Additional risk factors for patients in the
Intensive Care Unit (ICU) setting, such as perfusion, mechanical ventilation, and severity of
illness, are not included in the instrument but should also be assessed for a full understanding of
the level of risk and modifiable risks that can guide risk-based preventive interventions (EPUAP
et al., 2019).
NPIAP Pressure Injury Staging System
The NPIAP also developed the most used system for classifying pressure injuries
(Edsberg et al., 2016). Pressure injuries are classified (or staged) according to the depth of tissue
involved. The categories of classification are listed below. See Appendix A for NPIAP definitions
for each category (Edsberg et al., 2016).
•

Stage 1 – non-blanchable erythema of intact skin

•

Stage 2 - partial-thickness skin loss with exposed dermis

•

Stage 3 - full-thickness skin loss

•

Stage 4 - full-thickness skin and tissue loss

•

Unstageable - Obscured full-thickness skin and tissue loss
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•

Deep Tissue Pressure Injury – persistent non-blanchable deep red, maroon or purple
discoloration.

Mucosal pressure injuries are not staged due to the unique nature of the tissue involved. Mucosal
pressure injuries were included in the study as there is a lack of information regarding the
relationship between these pressure injuries and mortality. For each pressure injury, a
determination was made regarding whether a medical device caused it. Medical devices are a
common etiology of pressure injuries; the NPIAP recommends that medical device-related
pressure injuries be staged using the above classification system with a notation regarding the
device.
Pressure Ulcer Prevention Inventory
Identifying and limiting inclusion to unavoidable pressure injury was necessary to reduce
confounders attributed to nursing care. The Pressure Ulcer Prevention Inventory (PUPI) tool was
developed to identify a pressure injury as avoidable or unavoidable in acute care (Pittman et al.,
2016). The tool was used to build a Microsoft Office Excel spreadsheet to guide the chart reviews
to determine if appropriate assessments/reassessments, interventions, and care, modified as
appropriate, were documented three days before and when the pressure injury was first identified
(see Appendix E). The overall content validity was reported as .99, with an individual item
content validity score from .9 to 1.0. Interrater reliability was found to be excellent, and rater
agreement was 93%. For this study, a second review of eight (10%) of the charts was completed
by another wound nurse to determine inter-rater reliability. Percent agreement between the two
nurses was 100% for designation of avoidable vs. unavoidable status utilizing the PUPI Tool.
Outcome Measure of One-year Mortality
A date of death was often recorded in the EHR. If the date of death was not recorded and
no record of continued health care services indicating that the subject was alive one-year posthospitalization, obituary notices were searched, and National Death Index records were accessed.
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Data Management and Analysis
Data were recorded using Microsoft Excel, version 2009. The information was then
transferred to IBM SPSS Statistics (Version 27) for analysis. Data were secured using the Box
storage system, and all Health Insurance Portability and Accountability Act (HIPAA) regulations
were rigorously followed. A flow chart was developed to guide the analysis for each of the study
aims (see Appendix F). General descriptive analyses (e.g., frequencies, percentages, ranges,
means, and standard deviations) were conducted to check for outliers and possible data entry
errors. Outliers were found in the length of stay variable, and analyses were conducted for that
variable, including and excluding the outliers. Descriptive statistics were used to describe the
general characteristics of the sample.
Specific Aim 1: Determine the rate of occurrence of unavoidable pressure injuries in the
HAPI population using the PUPI tool.
A simple percentage was calculated using the number of unavoidable HAPI patients in
the numerator and the total number of HAPI patients (avoidable and unavoidable) in the
denominator x 100.
Specific Aim 2: Identify differences in comorbid conditions, pressure injury risk,
demographics, and living situations between those with unavoidable HAPI and the Control
group.
Independent sample t-tests were conducted to detect statistical differences for continuous
variables. Chi-square and Fisher's Exact tests were conducted for categorical variables.
Specific Aim 3: Determine if patients who develop an unavoidable HAPI are more likely to
die within one year than the matched controls, who remained pressure injury-free during
hospitalization.

40
Kaplan-Meier survival analysis and log-rank tests were conducted to determine mortality
risk differences within one-year of hospitalization.
Specific Aim 4: Identify risk factor differences in those with unavoidable HAPI that survive
for one year versus those with unavoidable HAPI that do not survive for one year.
Independent sample t-tests were conducted to detect statistical differences for continuous
variables. Chi-square was calculated for dichotomous variables. Fisher's exact test was run for
small sample sizes.
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CHAPTER 4
RESULTS
Analysis of Data
The purpose of the study was to explore the strength of the relationship between
unavoidable HAPI and increased risk of one-year post-hospitalization mortality for patients age
55 and older. The results of each of the four aims will be provided. Data were analyzed with IBM
SPSS Statistics (Version 27).
Sample Characteristics
Forty-eight unavoidable HAPI patients were identified and matched, using ICD-10 codes
for hospitalization and age range, to 47 patients who did not develop pressure injury during
hospitalization. The unavoidable HAPI group had 48 individuals, 32 males (66.7%), and 16
(33.3%) females. The Control group had 47 individuals, 28 males (59.6%) and 19 females
(40.4%). The Control group's age range was 57 to 91 years old on admission to the hospital with
a mean age of 68.5 years (SD = 9.2). The HAPI group's age range was 55 to 93 years old on
admission to the hospital with a mean age of 69 years (SD = 10). The two groups were
comparable at baseline for age, gender, and comorbidities. The HAPI group had 27 deaths (56%),
and the Control group had 26 deaths (55%).
Aim 1: Determine the rate of occurrence of unavoidable pressure injuries in the HAPI
population using the PUPI tool.
Of the 79 cases of HAPI that met the study's inclusion criteria, in 61cases (77%), the
pressure injury of interest was determined to be unavoidable by the primary investigator.
Determination of unavoidable was based upon completion of a chart review as guided by the
PUPI tool.
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Aim 2: Identify differences in comorbid conditions, pressure injury risk, demographics, and
living situations between those with unavoidable HAPI and the Control group.
Comorbid Conditions
The conditions included in the CCI tool, Appendix C, were used to define comorbid conditions of
interest. The CCI tool was used after the groups were selected and were not used as a basis for
subject selection. Table 6 shows the results of the analysis of the comorbid conditions between
the HAPI and Control groups. No statistically significant differences were found for any of the
two groups' conditions; the odds ratios’ confidence intervals includes 1.0 in all cases. Total CCI
Index scores (based on the sum of weighted comorbidity scores and age scores) were not
significantly different between the Control group (M = 5.81, SD = 2.16) and HAPI group (M =
6.04, SD = 2.02); t = 0.543, p = .588. This indicates that the risk of death was comparable
between groups on admission.
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Table 6
Comparison of Comorbid Conditions between HAPI and Control Group
Condition

Total
N=95
(n, %)

HAPI
N=48
(n, %)

Control
N=47
(n, %)

Test
Statistic

p-value

Odds Ratio
95% [CI]

Myocardial Infarction

13
(13.7%)

5
(10.4%)

8
(17.0%)

χ2 = 0.88

.349

1.76 [0.53-5.85]

Congestive Heart Failure

29
(30.5%)

14
(29.2%)

15
(31.9%)

χ2 = 0.09

.771

1.14 [0.48-2.73]

Peripheral Vascular
Disease

7
(7.7%)

1
(2.1%)

6
(12.8%)

Fisher's
Exact Test

.059

0.69 [0.8-59.52]

Cerebrovascular Disease

11
(11.6%)

4
(8.3%)

7
(14.9%)

χ2 = 1.0

.318

1.93 [0.52-7.07]

Dementia

2
(2.1%)

1
(2.1%)

1
(2.1%)

Fisher’s
Exact Test

1.0

1.02 [0.06-16.83]

Chronic Pulmonary Disease

18
(18.9%)

8
(16.7%)

10
(21.3%)

χ2 = 0.33

.566

1.35 [0.82-3.79]

Connective Tissue Disease

0

0

0

NA

NA

NA

Peptic Ulcer

4
(4.2%)

2
(4.2%)

2
(4.3%)

Fisher's
Exact Test

1.0

1.02 [0.14-7.57]

Mild Liver Disease

4
(4.2%)

2
(4.2%)

2
(4.3%)

Fisher's
Exact Test

1.0

1.02 [0.14-7.57]

Diabetes no complications

25
(26.3%)

13
(27.1%)

12
(25.5%)

χ2 = 0.029

.864

0.92 [0.37-2.30]

Diabetes with
complications

16
(16.8%)

8
(16.7%)

8
(17%)

χ2 = 0.002

.960

1.03 [0.35-3.00]

0

0

0

NA

NA

NA

26
(27.4%)

17
(35.4%)

9
(19.1%)

χ2 = 3.16

.080

0.43 [0.17-1.10]

Hemi or Paraplegia
Renal Disease

Note. Comparison of comorbid conditions continues next page.
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Table 6 Continued
Comparison of Comorbid Conditions between HAPI and Control Group
Condition

Total
N=95
(n, %)

HAPI
N=48
(n, %)

Control
N=47
(n, %)

Test
Statistic

p
value

Odds Ratio
95% [CI]

Cancer

16
(16.8%)

8
(16.7%)

8
(17%)

χ2 = 0.002

.96

1.03 [0.35-3.00]

Metastatic Cancer

5
(5.3%)

3
(6.3%)

2
(4.3%)

Fisher’s
Exact Test

1.0

0.67 [0.11-4.18]

Moderate to Severe
Liver Disease

6
(6.3%)

4
(8.3%)

2
(4.3%)

Fisher’s
Exact Test

.68

0.489 [.085-2.81]

0

0

0

NA

NA

NA

HIV/AIDS

Note. Comparison of comorbid conditions on admission as included in the CCI Index between
HAPI and Control Groups.

Pressure Injury Risk
The Braden Scale for Predicting Pressure Sore Risk, Appendix D, scores were collected
for admission and discharge days. The HAPI group had significantly lower discharge Braden
Scale total and selected subscale scores than the Control group; with sub-scores for Sensory (p =
.002), Activity (p = .022), Mobility (p = .019), Friction/Shear, (p < .001), and total score (p =
.002) (see Table 7). There were no statistically significant differences in Braden Scale subscales
or total scores on admission, indicating that the groups had comparable risk levels at baseline.
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Table 7
Comparison of Braden Total and Subscale Scores between HAPI and Control Group
Braden Score

HAPI

Control

Mean (SD)

Mean (SD)

Independent Sample
t-test Statistics
t
p- value

Sensory

3.1 (0.91)

3.21 (0.72)

-0.65

.520

Moisture

3.42 (0.85)

3.6 (0.5)

-1.26

.211

Activity

2.17 (1.08)

2.21 (0.98)

-0.22

.824

Mobility

2.63 (0.866)

2.77 (0.758)

-0.84

.401

Nutrition

2.54 (0.544)

2.53 (3.0)

0.087

.931

Friction/Shear

2.33 (0.595)

2.36 (0.605)

-0.23

.818

Total Score

16.19 (3.618)

16.7 (3.04)

-0.75

.455

Sensory

2.69 (0.80)

3.21 (0.78)

-3.24

.002*

Moisture

3.08 (0.79)

3.36 (0.61)

-1.92

.058

Activity

2.02 (1.0)

2.49 (0.95)

-2.34

.022*

Mobility

2.38 (0.73)

2.77 (0.86)

-2.38

.019*

Nutrition

2.52 (0.65)

2.72 (0.62)

-1.56

.123

Friction/Shear

1.79 (0.77)

2.36 (0.67)

-3.84

< .001**

Total Score

14.48 (3.78)

16.91 (3.68)

-3.18

.002*

Admission

Discharge

Total Braden Change
-1.71 (4.73)
0.23 (4.38)
-2.05
.043*
between Admission and
Discharge
Note. Independent t-test results comparing Braden Scale pressure injury risk scores (sub-scores & total score)
on admission and discharge.
*p < .05
**p < .001
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Living Situation
Information on the living situation at the time of admission was collected, and the
placement decision at the time of hospital discharge. There were eight patients (7 HAPI, 1
control) admitted from other hospitals, and the living situation at the time of admission was
unavailable. The results of the analysis treating each situation as a dichotomous variable are
presented in Table 8. When treated as an ordinal variable, a Mann Whitney U test demonstrated
no significant differences between groups for living situation on admission (U = 931.5, p = .911),
or discharge (U = 1044, p = .502).
Hospital Factors
Table 9 and Table 10 provide analysis information for factors shown in previous studies
associated with pressure injury development as the HAPI group was more likely to have had an
ICU stay. The HAPI group was significantly more likely to experience initial admission or
subsequent transfer(s) to the ICU during the hospital stay (p = .005). The number of days in the
ICU for the HAPI group had an outlier that resulted from a severely burned patient that remained
in the ICU for 81 days. When the days of stay included the outlier, the length of stay was
significantly higher (p = .047) for the HAPI group; there was no statistical difference when the
outlier was removed (p = .081) (see Table 9).
Vasopressors were ordered and administered more often for those with HAPI. The use of
any vasopressors was shown to be significantly greater in the HAPI group (p < .001), as did the
total number of vasopressors orders (p = .002). Three specific types of vasopressors were found
to have significantly greater use in the HAPI group – Norepinephrine (p = .017), Epinephrine (p =
.004), and Phenylephrine (p = .001).
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Table 8
Comparison of Living Situation on Admission and Discharge between HAPI and Control Groups
Living Situation

HAPI
N = 48
(n, %)

Control
N = 47
(n, %)

Test Statistic, p value

8
(16.7%)

11
(23.4%)

χ2 =0.67, p = .412

27
(56.3%)
1
(2.1%)

25
(53.2%)
4
(8.5%)

χ2 = 0.09 , p = .765

Skilled Nursing or
Rehabilitation Facility

5
(10.4%)

6
(12.8%)

χ2 = 0.13, p = .720

Other a

7
(14.6%)

1
(2.1%)

Fisher’s Exact Test, p = .059

1
(2.1%)

4
(8.5%)

Fisher’s Exact Test, p = .204

10
(20.8%)

9
(19.1%)

χ2 = 0.004, p = .837

0
(0%)

1
(2.1%)

Fisher’s Exact Test, p = .495

25
(52.1%)

22
(46.8%)

χ2 = 0.26, p = .607

4
(8.3%)

4
(8.5%)

Fisher’s Exact Test, p = 1.0

8
(16.7%)

7
(14.9%)

χ2 = 0.06, p = .813

On Admission
Home - Alone
Home with Others
Assisted Living

At Discharge
Home - Alone
Home with Others
Assisted Living
Skilled Nursing or
Rehabilitation Facility
Hospice
Died in Hospital

Fisher’s Exact Test, p = .204

Note. The patient's living situation during hospital admission and discharge is compared between HAPI and
Control groups. Because of rounding, percentages may not total 100.
a Patients were admitted from other hospitals, and information was not available regarding the type of
living situation before hospitalization.
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Table 9
Comparison of ICU Stays, Codes, and Surgeries between HAPI and Control Groups
Factor

HAPI
(N = 48)
(n, %)

Control
(N = 47)
(n, %)

Test Statistic, p value

ICU Stay

35
(72.9%)

21
(44.7%)

χ2 = 7.82, p = .005*

Days in ICU with an
outlier a

M = 9.54
SD = 14.59

M = 4.62
SD = 8.40

t = 2.01, p = .047*

Days in ICU without
outlier
of 81 days a

M = 8.02
SD = 10.20

M = 4.62
SD = 8.40

t = 1.77, p = .081

Codes & Rapid Responses

16
(33.3%)

15
(31/9%)

t = -0.15, p = .884

Number of Surgeries b

M = 1.19
SD =1.66

M = .68
SD = 1.0

t = -1.81, p = .075

M = 145.21
SD = 173.91

M = 96.45
SD = 155.19

t = 1.44, p = .153

Anesthesia Time in
Minutes a

Note. Hospitalization factors which were of interest in determining patient level of illness.
Abbreviation: ICU = Intensive Care Unit.
a

Analysis showed a statistically significant difference with the inclusion of an outlier of 81 days.

b

Analysis showed no statistically significant difference with outliers removed.

*p < .05
**p < .001
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Table 10
Comparison of MAP Abnormalities and Vasopressor Use between HAPI and Control Groups

Factor

HAPI
(N = 48)
(n, %)

Control
(N = 47)
(n, %)

Test Statistic, p value

M = 17.9,
SD = 4.93

M = 16.4,
SD = 10.64

t = 0.56, p = .577

Highest Abnormal MAP
Recorded a,b

M = 134.73
SD = 32.07

M = 128
SD = 18.79

t = -1.19, p = .235

Lowest Abnormal MAP
Recorded a,b,c

M = 44.93,
SD = 12.06

M = 49.70,
SD = 11.23

t = -1.39, p = .171

26
(20.8%)

9
(19.1%)

χ2 = 12.52 p < .001**

Vasopressin

8
(16.7%)

4
(8.5%)

χ2 = 1.43, p = .232

Norepinephrine

20
(41.7%)

9
(19.1%)

χ2 = 5.68, p = .017*

Epinephrine

14
(29.2%)

3
(6.4%)

χ2 = 8.39, p = .004*

0

2
(4.3%)

Fisher’s Exact Test, p = .242

10
(20.8%)

0

Fisher’s Exact Test, p = .001*

M = 1.19
SD = 1.44

M = 0.38
SD = 0.90

t = -3.28, p = .002*

Number of Days MAP
Recorded a

Vasopressors Administered

Dopamine
Phenylephrine
Total Number
Vasopressors

Note. Abbreviations: MAP, Mean Arterial Pressure.
a

Analysis showed no statistically significant difference with outliers removed.

b

Normal Range MAP Readings (60 – 100 mmHg) were not included in the analysis.

c

Lowest outliers removed as they were attributed to equipment measurement errors.

*p < .05
**p < .001
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Aim 3. Determine if patients who develop an unavoidable HAPI are more likely to die
within one year than the matched controls, who remained pressure injury-free during
hospitalization.
The HAPI group had 27 deaths (56%), and the Control group had 26 deaths (55%) (See
Figure 6). The range of days from hospital discharge to death was 0 to 330 for the HAPI group
and 1 to 362 for the Control group. Zero represented death in the hospital. The mean survival
time for the HAPI group was 72.9 days, 95% CI (0 to 90.7), and 69.7 days, 95% CI (0 to 30.4),
for the Control group. The Kaplan-Meier survival curves were similar by visual inspection, as
shown in Figure 6.

Figure 6
Kaplan-Meier Survival Curves for HAPI and Control Groups
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Aim 4. Identify risk factor differences in those with unavoidable HAPI that survive for one
year versus those with unavoidable HAPI that do not survive for one year.
Comorbid Conditions
The conditions included in the CCI tool, Appendix C, were used to define comorbid
conditions of interest. Table 11 shows the results of the comorbid conditions' analysis between
the HAPI survived and died groups. No statistically significant differences were found for any of
the conditions between the two groups.
Table 11
Comparison of Comorbid Conditions between HAPI Survived and Died
Condition

Total
(N=48)
(n, %)

Survived
(N=21)
(n, %)

Died
(N=27)
(n, %)

Test
Statistic

Myocardial Infarction

5
(10.4%)

2
(9.5%)

3
(11.1%)

Fisher’s
Exact Test

1.0

1.19 [0.18 to7.84]

Congestive Heart Failure

14
(29.2%)

5
(23.8%)

9
(33.3%)

χ2 = 0.52

.471

1.6 [0.44 to 5.78]

Peripheral Vascular Disease

1
(2.1%)

0
(0%)

1
(3.7%)

Fisher's
Exact Test

1.0

1.04 [0.96 to 1.12]

Cerebrovascular Disease

4
(8.3%)

2
(9.5%)

2
(7.4%)

Fisher’s
Exact Test

1.0

0.76 [0.1 to 5.9]

Dementia

1
(2.1%)

1
(4.8%)

0
(0%)

Fisher’s
Exact Test

.438

0.95 [0.87 to 1.05]

Chronic Pulmonary Disease

8
(16.7%)

6
(28.6%)

2
(7.4%)

Fisher’s
Exact Test

.115

0.2 [0.04 to 1.12]

Connective Tissue Disease

0

0

0

NA

NA

NA

2
(4.2%)

1
(4.8%)

1
(3.7%)

Fisher's
Exact Test

1.0

0.769 [0.05 to 13.07]

Peptic Ulcer

Note. Comparison of comorbid conditions continues next page.

pvalue

Odds Ratio
95% [CI]
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Table 11 Continued
Comparison of Comorbid Conditions between HAPI Survived and Died
Condition

Total
(N=48)
(n, %)

Survived
(N=21)
(n, %)

Died
(N=27)
(n, %)

Test
Statistic

Mild Liver Disease

2
(4.2%)

0
(%)

2
(7.4%)

Fisher's
Exact Test

.497

1.08 [0.971 to 1.2]

Diabetes w/o complications

13
(27.1%)

5
(23.8%)

8
(29.6%)

χ2 = 0.203

.653

1.347 [0.37 to 4.95]

Diabetes with complications

8
(16.7%)

4
(19%)

4
(14.8%)

Fisher’s
Exact Test

.715

0.74 [0.16 to 3.38]

0

0

0

NA

NA

NA

Renal Disease

17
(35.4%)

7
(33.3%)

10
(37%)

χ2 = 0.071

.79

1.18 [0.36 to 3.9]

Cancer

8
(16.7%)

4
(19%)

4
(14.8%)

Fisher’s
Exact Test

.715

0.74 [0.16 to 3.38]

Metastatic Cancer

4
(8.3%)

1
(4.8%)

3
(11.1%)

Fisher's
Exact Test

.246

1.13 [0.99 to 1.29]

Moderate to Severe Liver
Disease

6
(12.5%)

4
(19%)

2
(7.4%)

Fisher's
Exact Test

.621

2.5 [0.24 to 25.95]

0

0

0

NA

NA

NA

Hemi or Paraplegia

HIV/AIDS

pvalue

Odds Ratio
95% [CI]

Note. Comparison of comorbid conditions on admission as included in the CCI Index between HAPI
Survived and Died groups. Total CCI Index scores were not significantly different between the Survived
group (M = 5.81, SD = 1.91) and Died group (M = 6.22, SD = 2.12); t = 0.698, p = .489.
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Pressure Injury Risk
The Braden Scale for Predicting Pressure Sore Risk (Appendix D) scores were collected
for admission and discharge days. Table 12 shows the results of the Braden scores and that those
patients with HAPI that died had lower mean scores for selected subscale scores and total score
than those that survived. Independent t-test analysis found that those who died within one year
had significantly lower subscale scores on discharge for Activity (p < .001), Mobility (p = .004),
and Friction/Shear, (p = .014) as well as discharge Braden total score (p = .001). There were no
statistically significant differences between those who survived and died within one year in
Braden Scale subscale or total scores on admission, indicating that the groups had comparable
risk of pressure injuries on admission but began to show differences in risk status sometime
between admission and discharge. The relative change (i.e. no change, worse or better) in total
Braden score between admission and discharge is shown in Figure 7.
Description of Pressure Injuries
If the subject had more than one pressure injury, the worst pressure injury was chosen for
the study; the selection criteria is described in Chapter 3. Overall, the stages at the time of the
HAPI identification were: 3 (6.25%) were Stage 1; 10 (20.8%) were Stage 2; 6 (12.5%) were
Stage 3; no Stage 4; 6 (12.5%) were unstageable; 20 (41.5%) were deep tissue pressure injuries,
and 3 (6.25%) were mucosal injuries. For 10 of 48 HAPI subjects (20.8%), the worst pressure
injury was related to a medical device. Of the 10 medical device-related pressure injuries, 3 were
Stage 2; 1 was Stage 3; 1 was unstageable; 2 were deep tissue pressure injuries, and 3 were
mucosal membrane pressure injuries.
Days between admission and the development of the pressure injury are depicted in
Figure 8. HAPI was identified within two weeks of hospital admission in 25 of the 48 HAPI cases
(52.1%). Table 13 displays the differences in pressure injury stages between the time of diagnosis
and discharge. There were no differences between the groups that were shown to have statistical
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significance. Table 14 shows the change in the pressure injury condition from the time of
diagnosis to the day of discharge; assessment of change was based upon wound nurse
reassessment notes. Pressure injuries were considered worse if the stage increased and considered
the same if the same stage was noted on diagnosis and discharge. Pressure injuries that were
unstageable or deep tissue pressure injuries (DTPI) on initial diagnosis were considered
unchanged if Stage 3 or 4 was noted on discharge due to uncertainties surrounding the true depth
of unstageable and DTPI. No statistically significant differences were found between the two
groups.
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Table 12
Comparison of Braden Total and Subscale Scores between HAPI Survived and Died
Braden Score

Survived

Died

Independent Sample

N = 21

N = 27

Mean (SD)

Mean (SD)

t

p value

Sensory

3.33 (.91)

2.93 (.87)

1.57

.123

Moisture

3.52 (.60)

3.33 (1)

0.77

.445

Activity

2.19 (.98)

2.15 (1.1)

0.14

.890

Mobility

2.67 (.73)

2.59 (.97)

0.29

.772

Nutrition

2.62 (.49)

2.48 (.58)

0.87

.391

Friction/Shear

2.29 (.56)

2.37 (.63)

-0.49

.630

16.62 (3.11)

15.85 (4)

0.73

.472

Sensory

3.0 (.71)

2.89 (.75)

1.98

.054

Moisture

3.33 (.80)

3.36 (.61)

-1.92

.058

Activity

2.57 (.93)

1.59 (.84)

3.82

<.001**

Mobility

2.71 (.56)

2.11 (.75)

3.07

.004*

Nutrition

2.71 (.46)

2.37 (.74)

1.97

.055

Friction/Shear

2.1 (.77)

1.56 (.7)

2.54

.014*

16.43 (3.25)

12.96 (3.50)

3.51

.001*

t-test Statistics

Admission

Total Score
Discharge

Total Score

Note. Independent t-test results comparing Braden Scale pressure injury risk scores (sub-scores & total
score) on admission and discharge.
*p < .05
**p < .001
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Figure 7
Comparison of HAPI Subjects Who Died Versus Survived in Relation to Total Braden Score
Change between Admission and Discharge

Figure 8
Days Between Admission and Pressure Injury Development

57

Table 13
Pressure Injury Stage Comparison of the HAPI Survived and Died Groups
Description

Lived
N = 21
(n, %)

Died
N = 27
(n, %)

Test Statistic, p value

2
(9.5%)

1
(3.7%)

Fisher’s Exact Test, p = .74

Stage 2

5
(23.8%)

5
(18.5%)

χ2 = 0.201, p = .65

Stage 3

2
(9.5%)

4
(14.8%)

Fisher’s Exact Test, p = .68

Stage 4

0

0

NA

2
(9.5%)

4
(14.8%)

Fisher’s Exact Test, p = .68

DTPI

9
(42.9%)

11
(40.7%)

χ2 = 0.022, p = .88

Mucosal

1
(4.8%)

2
(7.4%)

Fisher’s Exact Test, p = 1.0

0

1
(3.7%)

Fisher’s Exact Test, p = 1.0

Stage 2

3
(14.3%)

4
(14.8%)

Fisher’s Exact Test, p = 1.0

Stage 3

4
(19%)

3
(11.1%)

Fisher’s Exact Test, p = .68

Stage 4

0

0

NA

Unstageable

3
(14.3%)

5
(18.5%)

Fisher’s Exact Test, p = 1.0

DTPI

3
(14.3%)

6
(22.2%)

Fisher’s Exact Test, p = .71

Mucosal

1
(4.8%)

1
(3.7%)

Fisher’s Exact Test, p = 1.0

Resolved

7
(33.3%)

7
(25.9%)

χ2 = 0.314, p = .58

On Admission
Stage 1

Unstageable

At Discharge
Stage 1
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Table 14
Pressure Injury Change Between Admission and Discharge of the HAPI Survived and Died Groups
Description
Worse
Same
Better but still present
Resolved (healed)

Lived
N = 21
(n, %)
3
(14.3%)

Died
N = 27
(n, %)
1
(3.7%)

Test Statistic, p value

11
(52.4%)

19
(70.4%)

χ2 = 1.63, p = .20

0

0

NA

7
(33.3%)

7
(25.9%)

χ2 = 1.631, p = .20

Fisher’s Exact Test, p = .31

Note. Because of rounding, may not add to 100.

Living Situation
Information on the living situation at the time of admission was collected, and the
placement decision at the time of hospital discharge. Seven patients were admitted from other
hospitals, and the living situation was unavailable at the time of admission. The results of the
analysis of treating each situation as a dichotomous variable are presented in Table 15. Patients
who were still alive one year after discharge were significantly more likely to have been
discharged to a skilled nursing or rehabilitation facility (p = .18). When treated as an ordinal
variable, a Mann Whitney U test demonstrated no significant differences between groups for
living situation on admission (U = 281.5, p = .963); however, the Mann Whitney U test showed a
statistically significant difference between the groups for living situation at discharge (U = 168, p
= .009) with those that lived more likely to be discharged to home with others and those that died
more likely to be discharged to hospice or die in the hospital.
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Hospital Factors
Table 16 and Table 17 provide analysis information for factors shown in previous studies
to be associated with pressure injury development. There were no statistically significant
differences between the groups based on the one-year survival of HAPI subjects. Although a risk
factor for the development of HAPI, vasopressors use was shown to have no statistical
differences that could also be used to differentiate one-year survival versus death in patients who
developed unavoidable HAPI.
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Table 15
Living Situation and Comparison of the HAPI Survived and Died Groups
Living Situation

Lived (N = 21)

Died (N = 27)

Test Statistic, p value

(n, %)

(n, %)

Home - Alone

3
(14.3%)

5
(18.5%)

Fisher’s Exact Test, p = 1.0

Home with Others

13
(61.9%)

14
(51.9%)

χ2 = 0.485, p = .486

0
(0%)

1
(3.7%)

Fisher’s Exact Test, p = 1.0

Skilled Nursing or
Rehabilitation Facility

2
(9.5%)

3
(11.1%)

Fisher’s Exact Test, p = 1.0

Other a

3
(14.3%)

4
(14.8%)

Fisher’s Exact Test, p = 1.0

0
(0%)

1
(3.7%)

Fisher’s Exact Test, p = 1.0

6
(28.6%)

4
(14.8%)

Fisher’s Exact Test, p = .297

0

0

NA

15
(71.4%)

10
(37%)

χ2 = 5.598 , p = .018*

Hospice

0
(0%)

4
(14.8%)

Fisher’s Exact Test, p = .12

Died in Hospital

0
(0%)

8
(29.6%)

Fisher’s Exact Test, p = .005*

Admission

Assisted Living

Discharge
Home - Alone
Home with Others
Assisted Living
Skilled Nursing or
Rehabilitation Facility

Note. The patient’s living situation at time of hospital admission and discharge are compared between survived
and died groups. Because of rounding, percentages may not total 100.
a

Patients were admitted from other hospitals and information not available regarding type of living situation

prior to hospitalization.
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Table 16
Comparison of the HAPI Died and Survived Groups and ICU Stays, Codes, and Vasopressor Use
Factor

Survived

Died

(N = 21)

(N = 27)

(n, %)

(n, %)

18

17

(85.7%)

(63%)

6 (28.6%)

10 (37%)

M = 15.67

M = 19.4

SD = 12.86

SD = 24.04

6 (28.6%)

10 (37%)

M = 1.17

M = 1.8

SD = 0.41

SD =0.79

9

17

(42.9%)

(63%)

2

6

(9.5%)

(22.2%)

7

13

(33.3%)

(48.1%)

6

8

(28.6%)

(29.7%)

Dopamine

0

0

NA

Phenylephrine

3

7

Fisher’s Exact Test, p = .48

(14.3%)

(25.9%)

ICU Stay

Days in ICU a

Codes & Rapid Responses

Vasopressors Administered

Vasopressin

Norepinephrine

Epinephrine

Test Statistic

χ2 = 3.096, p = .08

t = -0.348, p = .73

t = -1.809, p = .09

χ2 = 1.923, p = .17

Fisher’s Exact Test, p = .44

χ2 = 1.067, p = .30

χ2 = 0.006, p = .94

Note. Vasopressin have been found statistically significant in association with pressure injury development (Cox
& Roche, 2015) . ICU stay was been found statistically significant for pressure ulcer development in a study by
Lyder et al., 2012. There are no published reports that suggest these pressure injury risk factors are also risk
factors for one-year mortality. Abbreviations: ICU, Intensive Care Unit; NA, not applicable.
a

Analysis showed no statistically significant difference with outlier of 81 days.
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Table 17
Comparison of the HAPI Died and Survived Groups and MAP, Surgery Numbers, and Anesthesia
Time
Factor

Number of Days MAP a

Highest MAP Recorded a,b

Lowest MAP Recorded a,b,c

Number of Surgeries a

Anesthesia Time in
Minutes a

Survived

Died

(N = 21)

(N = 27)

(n, %)

(n, %)

21 (100%)

27 (100%)

M = 18.76

M = 17.22

SD = 11.91

SD = 17.11

20 (95.2%)

24 (88.9%)

M = 131.20

M = 137.67

SD = 25.017

SD = 37.22

10 (47.6%)

16 (59.3%)

M = 446.3

M = 48.56

SD = 4.08

SD = 7.80

13 (61.9%)

12 (44.4%)

M = 1.69

M = 2.92

SD =0.75

SD = 2.15

13 (61.9%)

12 (44.4%)

M = 305.85

M = 249.5

SD = 164.5

SD = 115.06

Test Statistic, p value

t = -0.351, p = .73

t = 0.662, p = .51

t = -0.968, p = .343

t = -1.869, p = .08

t = -1.0, p = .33

Note. Hospitalization factors which were of interest in determining patient level of illness. Abbreviations:
MAP = Mean Arterial Pressure.
a

Analysis showed no statistically significant difference with outliers removed.

b

Normal Range of MAP 60 – 100 mmHg; readings were outside of normal range.

c

Lowest outliers removed as they were attributed to equipment measurement errors.
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CCI Scores and Predictive Validity for One-Year Mortality
The total CCI Index scores (recorded upon hospital admission) were not significantly
different between the Survived group (M = 5.81, SD = 1.91) and Died group (M = 6.22, SD =
2.12); t = 0.698, p = .489. The Areas under Receiver Operating Curves were examined for the
entire sample and the HAPI and Control groups individually (see Table 18 and Figures 9, 10, and
11). The CCI was predictive for one-year mortality risk for the Control group but not the HAPI
group.

Table 18
Performance of the Total Charlson Comorbidity in Predicting One-Year Mortality in Total
Study Sample,, HAPI, and Control Group

Groups

N

Died Lived

AUROC p =
(95%
CI)

All

95 51

44

Subjects

.655

.006

(.545 .765)

Control

47 25

22

.753
( 612 -

<.001
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Figure 9
ROC Curve for HAPI and Control Groups – All Subjects

Figure 10
ROC Curve for Control Group
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Figure 11
ROC Curve for HAPI Group
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CHAPTER 5
SUMMARY
Discussion
This study found no significant difference in one-year survival rates between individuals
55 years and older who developed unavoidable HAPI and those who remained HAPI free, when
age and reason for hospitalization are comparable at baseline. Logistic regression was not
performed, as initially planned, as the variable sample sizes were less than the required 10
subjects per variable, and many of the variables demonstrating significant univariate differences
were intercorrelated or represented the same or very similar concepts. However, there were
intriguing findings that add to our understanding of the risk of mortality for patients with
unavoidable HAPI.
The similar rates of death between the HAPI (56%) and the Control group (55%) was
different than the two-fold rate reported in previous studies (Brown, 2003; Gorina et al., 2015;
Manzano et al., 2014; Walter et al., 2001). The meta-analysis of pressure injury studies and risk
of mortality completed by Song et al. (2019) also reported a two-fold increase in the risk of oneyear mortality. Wolkewitz et al. (2014) discuss how competing events outside the event of
interest can lead to flawed risk analysis; there may have been a reduction in competing events due
to this study's design.
Utilizing a structured chart review tool to determine the avoidability of the pressure
injury may have contributed to the result differences between this study and others reporting a
one-year risk of mortality by limiting the impact of nursing care quality as a competing event.
Previous studies using the PUPI instrument reported 39% and 41% of HAPI were determined to
be unavoidable pressure injuries, while this study found a rate of 77% (Pittman et al., 2016;
Pittman et al., 2019). The differences in the rate of unavoidable pressure injuries are most likely
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related to the subjects' ages; this study's mean age was approximately 10 years older than those in
the previous studies.
The matching strategy using the ICD-10 codes for the patient's reason for hospitalization
and age is the most likely cause for the similarity between the HAPI and Control groups. Analysis
found that both groups had similar age, admission and discharge living situations, and illness
burden, with illness burden defined as the biologic burden of comorbid conditions and
represented by the CCI comorbidities and total score. Studies, which pulled from large data
depositories without addressing illness burden, may have resulted in the Control group having a
lower illness burden than those who develop pressure injuries. The Pressure Ulcer Conceptual
Framework and the framework modified for this study are based on the premise that as the illness
burden increases, the body's ability to overcome pressure ulcer risk factors decline; the decline
concept can also be applied to those without pressure injury. The strategy of creating two groups
with similar illness burden may have resulted in the selection of a Control group with a more
significant illness burden than previous studies. The discharge Braden Scale and subscale scores
associated with sensory perception, mobility, activity and friction-shear were significantly lower
in the HAPI group in comparison to the Control group. Within the HAPI group, differences in
Braden scores were also found between those who lived and died; these will be discussed later.
The use of vasopressors and ICU stays are interconnected. The illness burden that
requires vasopressors also required ICU level care. These factors reflect the patient's critical
nature and increased risk of pressure injury (Cox & Roche, 2015). Cox and Roche also discussed
the potential contribution of vasopressors to unavoidable HAPI development. Although
vasopressors are often essential for maintaining perfusion to vital organs, they do so at the cost of
reduced perfusion to peripheral tissues which may be under pressure, making these tissues even
more susceptible to pressure injury. This study's statistical significance between the HAPI and
Control groups for ICU stays and vasopressor use was consistent with Cox and Roche's work.
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The illness burden associated with ICU stays and vasopressor use are events that impact the
development of unavoidable pressure injuries.
Examining the outcome of one-year mortality in the HAPI group found those who died
within one year had significantly lower Braden Scale total and subscale scores for activity,
mobility, and friction/shear on discharge. It is known that higher post-hospital mortality is
associated with poor mobility. Valiani et al. (2017) described in-hospital mobility as walking and
transferring; their study found the Braden subcategory of mobility had substantial prognostic
value for death within six months of hospital discharge. The Valiani study collected data only on
the mobility subscale.
This study found the HAPI survived group were more likely to be discharged to a skilled
nursing or rehabilitation facility than those HAPI patients who died within one year of discharge.
This difference may reflect the discharging physician's clinical judgment of the patient's potential
for rehabilitation in the case of one-year survivors and relative lack of rehabilitation potential for
those who died. The discharge placement decisions and discharge Braden Scale scores may
provide insights useful in developing a discharge plan of care.
CCI total scores upon admission were found to be predictive of one-year mortality risk
for all subjects and the Control group; both AUROC results compared favorably with those
reported in a study with a much larger sample size (Sundaranajan et al., 2004). The CCI did not
accurately predict the one-year mortality risk for the HAPI group. The presence of the pressure
injury had an unexplained effect on the CCI predicting accuracy.
Study Limitations
The small sample size and the use of a single site may have decreased the generalizability
of the study's findings.
The matching of the Control group to the HAPI group was problematic. The attempt to
use data fields to extract a pool of patients was not possible as the diagnosis of a pressure injury
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was seldom recorded in the patient's problem/medical diagnosis list. Only 8.2% (5 of 61) patients
with unavoidable HAPI had the injury included in the problem list. This lack of information
resulted in the necessity to check each potential match's chart to determine whether a HAPI had
occurred during the hospital stay of interest; 13.1% (11 of 84) of the patients identified as
potential matches were disqualified due to the presence of a HAPI discovered on chart
examination but not identified in an extractable field of the EHR. The failure to enter pressure
injuries in the problem list is multifaceted. It includes the focus of EHR for reimbursement of
care, the limiting of reimbursement of pressure injuries by CMS, the concern for punitive action
for hospital-acquired conditions, and the role of nursing versus physicians in identifying and
diagnosing pressure injuries. It is estimated that 80% of nursing data is unstructured and not
captured during a data pull (Papke, 2019). The invisibility of pressure injuries in data pulls affects
the ability to extract and examine information important in furthering our understanding of
pressure injuries and developing evidence-based nursing care.
The internal validity is threatened by the assumption that the cause of death is related to
disease burden and not accident or violence. The CDC (2017) reported unintentional injury was
the seventh cause of death for those aged 65 and over; approximately 2.7% of all deaths in this
age group.
The use of care documentation to determine unavoidability relies on the accuracy of all
data entries. The same is true of the Braden subscale scores that serve as a basis for
unavoidability determinations. As this was a retrospective chart review, the entries' reliability and
validity could not be directly verified. However, the researcher thoroughly examined each
medical record and believes the Braden Scale scores were generally consistent with the patients’
condition.
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Implications
The study's strength and the reasons for findings that differ from those of other one-year
mortality studies were the use of a tool to assess for avoidability and matching the Control group
by age and ICD 10 codes to verify similar illness burdens. These choices offer an opportunity for
future research on their effects on outcome results.
There appears to be an association between the Braden Scale subscales related to
mobilization (i.e. mobility, activity and friction-shear subscales) and an increased risk for oneyear post-hospitalization mortality. While the Braden Scale is used to assess the risk of pressure
injury development and provide guidance for nursing interventions, it may also provide an
objective measurement of the patient's illness burden as perceived by the nurse. Further research
into nurse perception of illness burden and Braden Scale decisions is needed. There may be an
opportunity to identify those with a greater risk of one-year mortality more accurately.
The differences found in Braden Scale scores indicate the instrument's usefulness; the
multidisciplinary efforts for pressure injury prevention are included in the PUPI chart review
process. The current recommendations for nursing interventions for the mobilization subscales of
activity, mobility, and friction/shear are designed to lower the risk of pressure injury
development. Enhancing interventions to improve in-hospital mobilization and reduce one-year
post-hospitalization mortality may be possible and is an additional area for future
interdisciplinary research with nursing and physical therapy.
The HAPI diagnosis's invisibility in the EHR has multiple consequences for patients,
health care systems and pressure injury research. Patient care is compromised during
hospitalization when pressure injuries are not recorded in problem lists so that all disciplines are
aware of this condition when planning coordinated wholistic care. Coders do not routinely
consult nursing documentation; pressure injuries that are not documented in the problem list or
providers’ notes frequently do not receive the proper ICD-10 code at discharge. Whilst under
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coding of pressure injuries may benefit the facility in terms of lower HAPI rates for state and
national reporting, it clearly does not provide the system with the accurate data needed for
effective continuous quality improvement. Under coding of pressure injuries may negatively
affect the patient’s post-hospital care. Providers may be unaware of pressure injuries that require
continued treatment and equipment payment authorization may be denied because it is based
upon the hospital ICD-10 codes. Future care is also compromised if the history of pressure injury
is not apparent. The inconsistent documentation of pressure injuries hampers the ability to collect
data needed to gain insights into pressure injuries and developing evidence-based practice
guidelines.
In order to enhance the reliability and validity of EHR databases for use in pressure
injury care, quality monitoring and research; several systematic changes should be implemented.
These include education to improve the accuracy of pressure injury identification and
classification by nurses and other health care professionals; recording appropriately classified
pressure injuries on patient problem lists and provider notes; developing structured fields in the
EHR for identifying and evaluating pressure injuries; and mapping pressure injuries to ICD
classification system and standardized computer terminologies such as LOINC (Logical
Observation Identifiers Names and Codes) and SNOMED-CT (Systematized Nomenclature of
Medicine – Clinical Terms) to facilitate data extraction for research.
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Appendix A
NPIAP Pressure Injury Stages
The updated staging system includes the following definitions:
Pressure Injury:
A pressure injury is localized damage to the skin and underlying soft tissue usually over a
bony prominence or related to a medical or other device. The injury can present as intact
skin or an open ulcer and may be painful. The injury occurs as a result of intense and/or
prolonged pressure or pressure in combination with shear. The tolerance of soft tissue for
pressure and shear may also be affected by microclimate, nutrition, perfusion, comorbidities and condition of the soft tissue.
Stage 1 Pressure Injury: Non-blanchable erythema of intact skin
Intact skin with a localized area of non-blanchable erythema, which may appear differently in
darkly pigmented skin. Presence of blanchable erythema or changes in sensation, temperature,
or firmness may precede visual changes. Color changes do not include purple or maroon
discoloration; these may indicate deep tissue pressure injury.
Stage 2 Pressure Injury: Partial-thickness skin loss with exposed dermis
Partial-thickness loss of skin with exposed dermis. The wound bed is viable, pink or red, moist,
and may also present as an intact or ruptured serum-filled blister. Adipose (fat) is not visible
and deeper tissues are not visible. Granulation tissue, slough and eschar are not present. These
injuries commonly result from adverse microclimate and shear in the skin over the pelvis and
shear in the heel. This stage should not be used to describe moisture associated skin damage
(MASD) including incontinence associated dermatitis (IAD), intertriginous dermatitis (ITD),
medical adhesive related skin injury (MARSI), or traumatic wounds (skin tears, burns,
abrasions).
Stage 3 Pressure Injury: Full-thickness skin loss
Full-thickness loss of skin, in which adipose (fat) is visible in the ulcer and granulation tissue
and epibole (rolled wound edges) are often present. Slough and/or eschar may be visible. The
depth of tissue damage varies by anatomical location; areas of significant adiposity can
develop deep wounds. Undermining and tunneling may occur. Fascia, muscle, tendon,
ligament, cartilage and/or bone are not exposed. If slough or eschar obscures the extent of
tissue loss this is an Unstageable Pressure Injury.
Stage 4 Pressure Injury: Full-thickness skin and tissue loss
Full-thickness skin and tissue loss with exposed or directly palpable fascia, muscle, tendon,
ligament, cartilage or bone in the ulcer. Slough and/or eschar may be visible. Epibole (rolled
edges), undermining and/or tunneling often occur. Depth varies by anatomical location. If
slough or eschar obscures the extent of tissue loss this is an Unstageable Pressure Injury.
Unstageable Pressure Injury: Obscured full-thickness skin and tissue loss
Full-thickness skin and tissue loss in which the extent of tissue damage within the ulcer cannot
be confirmed because it is obscured by slough or eschar. If slough or eschar is removed, a
Stage 3 or Stage 4 pressure injury will be revealed. Stable eschar (i.e. dry, adherent, intact
without erythema or fluctuance) on the heel or ischemic limb should not be softened or
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removed.
Deep Tissue Pressure Injury: Persistent non-blanchable deep red, maroon or
purple discoloration
Intact or non-intact skin with localized area of persistent non-blanchable deep red, maroon,
purple discoloration or epidermal separation revealing a dark wound bed or blood-filled blister.
Pain and temperature change often precede skin color changes. Discoloration may appear
differently in darkly pigmented skin. This injury results from intense and/or prolonged pressure
and shear forces at the bone-muscle interface. The wound may evolve rapidly to reveal the
actual extent of tissue injury or may resolve without tissue loss. If necrotic tissue, subcutaneous
tissue, granulation tissue, fascia, muscle or other underlying structures are visible, this
indicates a full thickness pressure injury (Unstageable, Stage 3 or Stage 4). Do not use DTPI to
describe vascular, traumatic, neuropathic, or dermatologic conditions.
Additional pressure injury definitions.
Medical Device Related Pressure Injury: Medical device related pressure injuries result from
the use of devices designed and applied for diagnostic or therapeutic purposes. The resultant
pressure injury generally conforms to the pattern or shape of the device. The injury should be
staged using the staging system. This describes an etiology.
Mucosal Membrane Pressure Injury: Mucosal membrane pressure injury is found on
mucous membranes with a history of a medical device in use at the location of the injury. Due
to the anatomy of the tissue these ulcers cannot be staged.
Source: National Pressure Injury Advisory Panel. (2020, October 16). NPIAP Pressure Injury
Stages.
https://cdn.ymaws.com/npiap.com/resource/resmgr/online_store/npiap_pressure_injury_stages.
pdf
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Appendix B

Qualitative Study Appraisal Form
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Appendix C
Charlson Comorbidity Index Scoring System

Score

Condition

1

Myocardial infarction (diagnosis)

1

Congestive heart failure

1

Peripheral vascular disease

1

Cerebrovascular disease

1

Dementia

1

Chronic pulmonary disease

1

Connective tissue disease

1

Peptic ulcer disease

1

Mild liver disease

1

Diabetes without chronic complications

2

Hemiplegia or Paraplegia

2

Moderate or severe renal disease

2

Diabetes with end-organ damage

2

Cancer without metastasis, leukemia,
lymphoma

3

Cancer with metastasis

3

Moderate to severe liver disease

6

HIV/AIDS
AGE

2

55-60

3

61-70

4

71+
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Appendix D
Braden Scale for Predicting Pressure Ulcer Risk Scoring
Sensory
Perception

1 – Completely Limited:
Unresponsive (does not
moan, flinch or grasp) to
painful stimuli, due to
diminished level of
consciousness or sedation.
OR
Limited ability to feel
pain over most of body
surface.

2 – Very Limited:
Responds only to painful
stimuli
Cannot communication
discomfort except for
moaning or restlessness,
OR
Has a sensory impairment,
which limits the ability to
feel pain or discomfort over
½ of body.

1 – Constantly Moist:
Perspiration, urine, etc.,
keep skin moist almost
constantly. Dampness is
detected every time
patient is moved or
turned.
1 – Bedfast:
Confined to Bed

2 – Moist:
Skin is often but not always
moist.
Linen must be changed at
least once a shift.

Mobility
Ability to change
and control body
position

1 – Completely Immobile:
Does not make even slight
changes in body or
extremity position without
assistance.

Nutrition
Usual food
intake pattern

1 – Very Poor:
Never eats a complete
meal. Rarely eats more
than 1/3 of any food
offered. Eats 2 servings or
less of protein (meat or
dairy products) per day.
Takes fluids poorly. Does
not take a liquid dietary
supplement,
OR
Is NPO and/or maintained
on clear liquids or IV
more than 5 days.

2 – Very Limited:
Makes occasional slight
changes in body or
extremity position but
unable to make frequent or
significant changes
independently.
2 – Probably Inadequate:
Rarely eats a complete
meal and generally eats
only about ½ of any food
offered. Protein intake
includes only 3 servings of
meat or dairy products per
day. Occasionally will take
a dietary supplement,
OR
Receives less than
optimum amount of liquid
diet or tube feeding.

Friction and
Shear

1 – Problem:
Requires moderate to
maximum assistance in
moving. Complete lifting
without sliding against
sheets is impossible.
Frequently slides down in
bed or chair, requiring
frequent repositioning
with maximum assistance.
Spasticity, contractures, or
agitation leads to almost
constant friction.

Ability to
respond
meaningfully to
pressure related
discomfort

Moisture
Degree to which
skin is exposed
to moisture

Activity
Degree of
physical activity

2 – Chairfast:
Ability to walk severely
limited or nonexistent.
Cannot bear own weight
and/or must be assisted into
chair or wheelchair.

2 – Potential Problem:
Moves feebly or require
es minimum assistance.
During a move skin
probably slides to some
extent against sheets, chair,
restraints, or other devices.
Maintains relatively good
position in chair or bed
most of the time but
occasionally slides down.

3 – Slightly Limited:
Responds to verbal
commands but cannot
always communication
discomfort or need to
be turned,
OR
Has some sensory
impairment, which
limits ability to feel
pain or discomfort in1
or 2 extremities.
3 – Occasionally Moist:
Skin occasionally
moist, requiring an
extra linen change
approximately once a
day.

4 – No Impairment:
Responds to verbal
command. Has no
sensory deficit which
would limit ability to
feel or voice pain or
discomfort.

3 – Walks
Occasionally:
Walks occasionally
during day but for very
short distances, with or
without assistance.
Spends majority of
each shift in bed or
chair.
3 – Slightly Limited:
Makes frequent thought
slight changes in body
or extremity position
independently.

4 – Walks Frequently:
Walks outside the
room at least twice a
day and inside room at
least once every 2
hours during waking
hours.

3 – Adequate:
Easts over half of most
meals. Eats a total of 4
servings of protein
(meat or dairy
products) each day.
Occasionally will
refuse a meal, but will
usually take a
supplement if offered,
OR
Is on a tube feeding or
TPN regimen, which
probably meets most of
nutritional needs.
3 – No Apparent
Problem:
Moves in bed and in
chair independently and
has sufficient muscle
strength to lift-up
completely during
move. Maintains good
position in bed or chair
at all times.

4 – Excellent:
Eats most of every
meal. Never refuses a
meal. Usually eats a
total of 4 or more
servings of meat and
dairy products.
Occasionally eats
between meals.
Does not require
supplementation.

4 – Rarely Moist:
Skin is usually dry;
linen requires
changing only at
routine intervals.

4 – No Limitations:
Makes major and
frequent changes in
position without
assistance.
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Appendix E
PUPI Excel Spreadsheet

88

Appendix F
Flow Chart for Data Collection

89
APPENDIX G
Permission to Use Pressure Ulcer Conceptual Framework Figure
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APPENDIX H
Permission to Use PUPI Tool
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